DYRK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S6 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | _______________MSKSEsPKEPEQLRKLFIGGLsFEtT |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00178 | S12 | Sugiyama | GTPBP1 | _________MATERsRsAMDsPVPAsMFAPEPssPGAARAA |
| O00178 | S6 | Sugiyama | GTPBP1 | _______________MATERsRsAMDsPVPAsMFAPEPssP |
| O00178 | S8 | Sugiyama | GTPBP1 | _____________MATERsRsAMDsPVPAsMFAPEPssPGA |
| O00193 | S17 | Sugiyama | SMAP C11orf58 | ____MsAARESHPHGVKRsAsPDDDLGssNWEAADLGNEER |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00468 | S738 | Sugiyama | AGRN AGRIN | CGSDGVTYSTECELKKARCEsQRGLYVAAQGACRGPTFAPL |
| O00499 | S298 | Sugiyama | BIN1 AMPHL | TFtVKAQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEP |
| O00499 | T307 | Sugiyama | BIN1 AMPHL | DNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEPAGGAtPGAt |
| O00562 | S326 | Sugiyama | PITPNM1 DRES9 NIR2 PITPNM | GKQWSSSSRssYsSQHGGAVsPQSLsEWRMQNIARDSENSS |
| O14556 | T301 | Sugiyama | GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 | ASTGAAKAVTKVIPELKGKLtGMAFRVPTPDVSVVDLTCRL |
| O14639 | S431 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | TSGYDDKQERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRst |
| O15031 | S650 | Sugiyama | PLXNB2 KIAA0315 | CVSNRWTCQWDLRYHECREAsPNPEDGIVRAHMEDSCPQFL |
| O15037 | S291 | Sugiyama | KHNYN KIAA0323 | GWKELPGEEAWEREVALRPQsVGGGAREsAPLKGKALGKEE |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O15160 | S258 | Sugiyama | POLR1C POLR1E | DITLLEPVEGEAAEELSRCFsPGVIEVQEVQGKKVARVANP |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O60271 | S1188 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | ISIPLTETNKTSGVPGNRPGsVIRVYGDENSDKVTPGTFIP |
| O60271 | S194 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | LERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLPAGDG |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75122 | S21 | Sugiyama | CLASP2 KIAA0627 | MAMGDDKsFDDEEsVDGNRPssAAsAFKVPAPKTSGNPANS |
| O75131 | S242 | Sugiyama | CPNE3 CPN3 KIAA0636 | SHDLIGTFQTTMTKLKEAsRssPVEFECINEKKRQKKKSYK |
| O75179 | S2401 | Sugiyama | ANKRD17 GTAR KIAA0697 | CSSASNDSSAQSVSSGVRAPsPAPssVPLGSEKPSNVSQDR |
| O75376 | S157 | Sugiyama | NCOR1 KIAA1047 | LRASADAKKDPAFGGKHEAPssPIsGQPCGDDQNAsPsKLS |
| O75792 | S18 | Sugiyama | RNASEH2A RNASEHI RNHIA | ___MDLSELERDNTGRCRLssPVPAVCRKEPCVLGVDEAGR |
| O94776 | S435 | Sugiyama | MTA2 MTA1L1 PID | RGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFL |
| O94808 | S202 | Sugiyama | GFPT2 | FALVFKSVHYPGEAVATRRGsPLLIGVRSKYKLSTEQIPIL |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94842 | S178 | Sugiyama | TOX4 C14orf92 KIAA0737 | GGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLPSQ |
| O94842 | T176 | Sugiyama | TOX4 C14orf92 KIAA0737 | SLGGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLP |
| O95071 | S1308 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | VEHCQYRPPRIREDRNRKtAsPEDsDMPDHDLEPPRFAQLA |
| O95149 | S350 | Sugiyama | SNUPN RNUT1 SPN1 | ENGHyELEHLstPKLKGssHsPDHPGCLMEN__________ |
| O95503 | S280 | Sugiyama | CBX6 | LLAAPAAPYDARssGssGCPsPtPQSSDPDDTPPKLLPETV |
| O95503 | T282 | Sugiyama | CBX6 | AAPAAPYDARssGssGCPsPtPQSSDPDDTPPKLLPETVsP |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | T229 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | AstGAAKAVGKVIPELNGKLtGMAFRVPtANVsVVDLtCRL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T65 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQ |
| P07942 | T1141 | Sugiyama | LAMB1 | FWGDPDVECRACDCDPRGIEtPQCDQSTGQCVCVEGVEGPR |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | T60 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| P08651 | S339 | Sugiyama | NFIC NFI | GGIssPVKKtEMDKsPFNsPsPQDsPRLSsFTQHHRPVIAV |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09651 | S6 | Sugiyama | HNRNPA1 HNRPA1 | _______________MsKsEsPKEPEQLRKLFIGGLsFEtT |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P12277 | S163 | Sugiyama | CKB CKBB | PPHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S442 | Sugiyama | PRKCSH G19P1 | EYVYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSA |
| P14314 | T444 | Sugiyama | PRKCSH G19P1 | VYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMK |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P17066 | T40 | Sugiyama | HSPA6 HSP70B' | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17844 | S519 | Sugiyama | DDX5 G17P1 HELR HLR1 | AGKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAAN |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P18754 | S11 | Sugiyama | RCC1 CHC1 | __________MsPKRIAKRRsPPADAIPKsKKVKVsHRsHs |
| P18827 | S233 | Sugiyama | SDC1 SDC | FETSGENTAVVAVEPDRRNQsPVDQGAtGAsQGLLDRKEVL |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | Y353 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GGNyGPGGsGGsGGyGGRsRy____________________ |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23588 | S311 | Sugiyama | EIF4B | YRGGGDRYEDRYDRRDDRsWssRDDysRDDYRRDDRGPPQR |
| P25054 | S2022 | Sugiyama | APC DP2.5 | PQASGYAPKSFHVEDTPVCFsRNSSLSSLSIDsEDDLLQEC |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P27708 | S1038 | Sugiyama | CAD | QLPNNMAMALHRQQCRVLGtsPEAIDSAENRFKFSRLLDTI |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P28066 | S16 | Sugiyama | PSMA5 | _____MFLTRsEyDRGVNtFsPEGRLFQVEyAIEAIKLGST |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28799 | T182 | Sugiyama | GRN | VHCCPHGAFCDLVHTRCItPtGTHPLAKKLPAQRTNRAVAL |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P33176 | S175 | Sugiyama | KIF5B KNS KNS1 | VHEDKNRVPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVT |
| P33316 | S88 | Sugiyama | DUT | RGASTVGAAGWKGELPKAGGsPAPGPEtPAIsPsKRARPAE |
| P33992 | S315 | Sugiyama | MCM5 CDC46 | RVLGIQVDTDGSGRSFAGAVsPQEEEEFRRLAALPNVYEVI |
| P34896 | T405 | Sugiyama | SHMT1 | NKNTCPGDRSALRPSGLRLGtPALTSRGLLEKDFQKVAHFI |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P35606 | S859 | Sugiyama | COPB2 | GKDFQPSRstAQQELDGKPAsPtPVIVAsHtANKEEKSLLE |
| P35606 | T861 | Sugiyama | COPB2 | DFQPSRstAQQELDGKPAsPtPVIVAsHtANKEEKSLLELE |
| P35613 | S278 | Sugiyama | BSG UNQ6505/PRO21383 | ITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQ |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42765 | T227 | Sugiyama | ACAA2 | EVKTKKGKQTMQVDEHARPQtTLEQLQKLPPVFKKDGTVTA |
| P42898 | T34 | Sugiyama | MTHFR | CLEGSASSGSESSKDSSRCStPGLDPERHERLREKMRRRLE |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46013 | S2105 | Sugiyama | MKI67 | tPDHTEESttDDKTTKIACKsPPPEsMDtPTstRRRPKtPL |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46777 | T232 | Sugiyama | RPL5 MSTP030 | MEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPV |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48741 | T40 | Sugiyama | HSPA7 HSP70B | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P49023 | S303 | Sugiyama | PXN | QRADGERCWAAGWPRDGGRssPGGQDEGGFMAQGKtGsssP |
| P49327 | S974 | Sugiyama | FASN FAS | VSGKVyQWDDPDPRLFDHPEsPtPNPTEPLFLAQAEVYKEL |
| P49327 | T2204 | Sugiyama | FASN FAS | LRKLQELSSKADEAsELACPtPKEDGLAQQQtQLNLRSLLV |
| P49757 | S634 | Sugiyama | NUMB C14orf41 | DPFEAQWAALENKSKQRtNPsPtNPFSSDLQKTFEIEL___ |
| P50748 | S1034 | Sugiyama | KNTC1 KIAA0166 ROD | DLREQHIKAHEVAQAKHKPGstPEPIAAEVRsPsMEsKLHR |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51991 | S356 | Sugiyama | HNRNPA3 HNRPA3 | SGQQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsR |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P51991 | Y360 | Sugiyama | HNRNPA3 HNRPA3 | QSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF__ |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53992 | S328 | Sugiyama | SEC24C KIAA0079 | sQPGPPQPLPPKRLDPDAIPsPIQVIEDDRNNRGTEPFVTG |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55072 | S718 | Sugiyama | VCP HEL-220 HEL-S-70 | AIREsIEsEIRRERERQtNPsAMEVEEDDPVPEIRRDHFEE |
| P55081 | T267 | Sugiyama | MFAP1 | ETKKELEENKRsLAALDALNtDDENDEEEyEAWKVRELKRI |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61254 | S32 | Sugiyama | RPL26 | sKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRKD |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62995 | T201 | Sugiyama | TRA2B SFRS10 | GMELDGRRIRVDFSITKRPHtPtPGIyMGRPtYGssRRRDY |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00059 | S160 | Sugiyama | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | T367 | Sugiyama | HSF1 HSTF1 | ALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDH |
| Q01082 | S2197 | Sugiyama | SPTBN1 SPTB2 | KTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNKKA |
| Q01082 | T2192 | Sugiyama | SPTBN1 SPTB2 | sDRKAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEA |
| Q01082 | T2195 | Sugiyama | SPTBN1 SPTB2 | KAKTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNK |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01844 | S274 | Sugiyama | EWSR1 EWS | YSQQSSSYGQQSsFRQDHPssMGVyGQESGGFSGPGENRSM |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q06210 | S205 | Sugiyama | GFPT1 GFAT GFPT | FALVFKSVHFPGQAVGTRRGsPLLIGVRSEHKLSTDHIPIL |
| Q07157 | S912 | Sugiyama | TJP1 ZO1 | NQtyPPYsPQAQPQPIHRIDsPGFKPAsQQKAEAssPVPyL |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S1321 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAsttssV |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S456 | Sugiyama | NSUN2 SAKI TRM4 | NKRQPKLQGKSAEtREstQLsPADLTEGKPTDPSKLEsPsF |
| Q09666 | S230 | Sugiyama | AHNAK PM227 | sGsGAAsPtGsAVDIRAGAIsAsGPELQGAGHsKLQVTMPG |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q13098 | S485 | Sugiyama | GPS1 COPS1 CSN1 | HVKsPPREGsQGELtPANsQsRMstNM______________ |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13263 | T415 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LNAWTKSAEAFGKIVAERPGtNstGPAPMAPPRAPGPLSKQ |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13427 | T358 | Sugiyama | PPIG | PRRYRTPSRSRSRDRFRRsEtPPHWRQEMQRAQRMRVssGE |
| Q13438 | S529 | Sugiyama | OS9 | sPELVKKHKKKRVVPKKPPPsPQPTEEDPEHRVRVRVTKLR |
| Q13501 | S266 | Sugiyama | SQSTM1 ORCA OSIL | AALsPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQP |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q13895 | S423 | Sugiyama | BYSL ENP1 | ELLRLQPHPQLsPEIRRELQsAVPRDVEDVPITVE______ |
| Q14157 | S477 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLTSK |
| Q14160 | S1486 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RHQERLRVQsPEPPAPERALsPAELRALEAEKRALWRAARM |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14203 | S31 | Sugiyama | DCTN1 | RTPSGSRMsAEASARPLRVGsRVEVIGKGHRGTVAYVGATL |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15637 | S80 | Sugiyama | SF1 ZFM1 ZNF162 | DLTRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFR |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15642 | S495 | Sugiyama | TRIP10 CIP4 STOT STP | VLsNRGDsLSRHARPPDPPAsAPPDsssNsAsQDtKESSEE |
| Q15738 | S106 | Sugiyama | NSDHL H105E3 | CSRQDLyPALKGVNTVFHCAsPPPSSNNKELFYRVNYIGTK |
| Q15814 | S330 | Sugiyama | TBCC | RSKNNWNDVDDFNWLARDMAsPNWsILPEEERNIQWD____ |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q32MZ4 | S733 | Sugiyama | LRRFIP1 GCF2 TRIP | ssPAEPKsEDADRCtLPEHEsPsQDIsDACEAEsTERCEMS |
| Q58FF6 | T36 | Sugiyama | HSP90AB4P | LQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPNPR |
| Q58FF7 | T60 | Sugiyama | HSP90AB3P HSP90BC | LQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| Q58FF8 | T60 | Sugiyama | HSP90AB2P HSP90BB | LWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQ |
| Q5JSH3 | S50 | Sugiyama | WDR44 RPH11 | KVGLSTFKETENTAYKVGNEsPVQELKQDVSKKIIEsIIEE |
| Q5JSH3 | S561 | Sugiyama | WDR44 RPH11 | KNAFDYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVC |
| Q5SW79 | T1533 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | LPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAVSAAA |
| Q5T200 | S879 | Sugiyama | ZC3H13 KIAA0853 | EKHRLLsQVVRPQEsRsLsPsHLTEDRQGRWKEEDRKPERK |
| Q6GYQ0 | S861 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQM |
| Q6GYQ0 | T1002 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | TITGSESASPVHSPLGSRsQtPsPSTLNIDHMEQKDLQLDE |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6NW29 | S23 | Sugiyama | RWDD4 FAM28A RWDD4A | ANEDQEMELEALRSIyEGDEsFRELsPVSFQyRIGENGDPK |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q6ZN18 | S141 | Sugiyama | AEBP2 | SAESLVGSSGGSSSDETRsLsPGAAssssGDGDGKEGLEEP |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | S69 | Sugiyama | MEPCE BCDIN3 | RGPGRCAPsAGsPAAAVGREsPGAAAtsSSGPQAQQHRGGG |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z2W4 | S275 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | QGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDLtR |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z4H7 | S552 | Sugiyama | HAUS6 DGT6 FAM29A KIAA1574 | PFQKEQDHLVEEVARAVLsDsPQLsEGKEIKLEELIDsLGS |
| Q7Z4V5 | S183 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KMsVSKRARKASSDLDQAsVsPSEEENSESSsESEKTsDQD |
| Q7Z4V5 | S652 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | GssEDLHDsVREGPDLDRPGsDRQERERARGDsEALDEEs_ |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5L9 | S240 | Sugiyama | IRF2BP2 | AAASLGSAQPTDLGAHKRPAsVsssAAVEHEQREAAAKEKQ |
| Q7Z5L9 | S360 | Sugiyama | IRF2BP2 | EANGANGSKAVARTARKRKPsPEPEGEVGPPKINGEAQPWL |
| Q7Z6Z7 | S2887 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | LEEAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGs |
| Q86VM9 | S607 | Sugiyama | ZC3H18 NHN1 | SRHSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAP |
| Q86VM9 | S609 | Sugiyama | ZC3H18 NHN1 | HSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPP |
| Q86VQ1 | S108 | Sugiyama | GLCCI1 | AAASLGSLPGPGAARGPsPssPtPPAAAAPAEQAPRAKGRP |
| Q86WR0 | S187 | Sugiyama | CCDC25 | KKREKEEMKKKREMDELRSYssLMKVENMSSNQDGNDsDEF |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8N684 | T161 | Sugiyama | CPSF7 | LLELLPGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVP |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T3 | S343 | Sugiyama | ARFGAP1 ARF1GAP | NIDQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDs |
| Q8N6T3 | T340 | Sugiyama | ARFGAP1 ARF1GAP | QNSNIDQSFWETFGSAEPTKtRKsPssDsWtCADtstERRs |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8ND56 | S183 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GSAFTQDTRsLKtQLsQGRssPQLDPLRKsPtMEQAVQtAs |
| Q8NEY1 | S312 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | TCYDsDDANPRsVssLsNRssPLSWRYGQSSPRLQAGDAPS |
| Q8TAD8 | S35 | Sugiyama | SNIP1 | RHRDGDVVLPAGVVVKQERLsPEVAPPAHRRPDHsGGsPsP |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TD19 | S13 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | ________MsVLGEYERHCDsINSDFGSEsGGCGDssPGPS |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8WVC0 | S495 | Sugiyama | LEO1 RDL | QGtGLQGQAVFKTKLTFRPHstDSATHRKMTLSLADRCSKT |
| Q8WVV9 | S75 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | GGGRsFsQPEAGGsHHKVsVsPVVHVRGLCEsVVEADLVEA |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q8WY36 | S844 | Sugiyama | BBX HBP2 | KRKARKTKITHLVRtADGRVsPAGGTLDDKPKEQLQRSLPK |
| Q92466 | S26 | Sugiyama | DDB2 | RPETQKTSEIVLRPRNKRsRsPLELEPEAKKLCAKGSGPSR |
| Q92620 | S234 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | TWEEEDsGyGSSRRSQWEsPsPTPSYRDSERSHRLSTRDRD |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96BY7 | S1395 | Sugiyama | ATG2B C14orf103 | ADMKPGAFQRRSKVDSSGRSsSRGPVLPEADQQMLRDLMSD |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96EN8 | S530 | Sugiyama | MOCOS | APSADSQADVIPAVMGRRsLsPQEDALTGSRVWNNSSTVNA |
| Q96L14 | T242 | Sugiyama | CEP170P1 CEP170L KIAA0470L | LPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAVSAAA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96QF0 | S165 | Sugiyama | RAB3IP RABIN8 | DGSDDIFGLsTDSLSRLRsPsVLEVREKGYERLKEELAKAQ |
| Q96QK1 | S783 | Sugiyama | VPS35 MEM3 TCCCTA00141 | tEQINKHFHNtLEHLRLRREsPEsEGPIyEGLIL_______ |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96T37 | S670 | Sugiyama | RBM15 OTT OTT1 | GRHLDRsPEsDRPRKRHCAPsPDRsPELsssRDRYNsDNDR |
| Q99426 | S163 | Sugiyama | TBCB CG22 CKAP1 | AEAAQRLAEEKAQASSIPVGsRCEVRAAGQSPRRGTVMYVG |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q9BQG0 | S1232 | Sugiyama | MYBBP1A P160 | KRNRTKAKVPAQANGtPtTKsPAPGAPtRsPstPAKsPKLQ |
| Q9BSJ8 | S1034 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | LLPDKNRGTKRRTSQKKRtLsPEFNERFEWELPLDEAQRRK |
| Q9BTA9 | S525 | Sugiyama | WAC KIAA1844 | QGHEPVsPRSLQRsssQRsPsPGPNHtsNssNAsNATVVPQ |
| Q9BTC0 | T1469 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | CADVRRNsVERPAEPVAGAAtPsLVEQQKMLEELNKQIEEQ |
| Q9BV68 | S34 | Sugiyama | RNF126 | HCCsVEIVPRLPDYICPRCEsGFIEELPEETRSTENGSAPS |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9BY44 | S506 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | KNQRKHEAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQs |
| Q9BY44 | T512 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | EAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPE |
| Q9BYG3 | T234 | Sugiyama | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S422 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | RTFPSGGEEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEK |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S983 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGGsSRtLDAQDRsFGtRPLssGFsPEEAQQQDEEFEKKIP |
| Q9C0C2 | S984 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GGsSRtLDAQDRsFGtRPLssGFsPEEAQQQDEEFEKKIPs |
| Q9C0C2 | S987 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | SRtLDAQDRsFGtRPLssGFsPEEAQQQDEEFEKKIPsVED |
| Q9C0C9 | S115 | Sugiyama | UBE2O KIAA1734 | GRGssGCSEAGGAGHEEGRAsPLRRGYVRVQWYPEGVKQHV |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4A4 | S19 | Sugiyama | RNPEP APB | __MAsGEHsPGsGAARRPLHsAQAVDVAsAsNFRAFELLHL |
| Q9H4A5 | S112 | Sugiyama | GOLPH3L GPP34R | EPPTMRKKRLLDRKVLLKsDsPTGDVLLDETLKHIKATEPT |
| Q9H4G0 | S784 | Sugiyama | EPB41L1 KIAA0338 | KGAAAMIPGPQTVATEIRsLsPIIGKDVLtstyGAtAEtLS |
| Q9HA77 | S548 | Sugiyama | CARS2 OK/SW-cl.10 | TLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG____ |
| Q9HA77 | T547 | Sugiyama | CARS2 OK/SW-cl.10 | DTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG___ |
| Q9HAU0 | S471 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | MARYPEGYRtLPRNSKTRPEsICSVtPsTHDKTLGPGAEEK |
| Q9HC35 | S144 | Sugiyama | EML4 C2orf2 EMAPL4 | GQREKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsK |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NPI6 | S523 | Sugiyama | DCP1A SMIF | APSVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILS |
| Q9NPI6 | S525 | Sugiyama | DCP1A SMIF | SVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKs |
| Q9NR20 | S16 | Sugiyama | DYRK4 | _____MPASELKASEIPFHPsIKTQDPKAEEKSPKKQKVTL |
| Q9NR20 | S420 | Sugiyama | DYRK4 | IHQSRNLKPQPRPQTLRKSNsFFPSETRKDKVQGCHHSSRK |
| Q9NR20 | S498 | Sugiyama | DYRK4 | QLPQLVDAPKKSEAAVGAEVsMtsPGQSKNFSLKNTNVLPP |
| Q9NR20 | S501 | Sugiyama | DYRK4 | QLVDAPKKSEAAVGAEVsMtsPGQSKNFSLKNTNVLPPIV_ |
| Q9NR20 | T476 | Sugiyama | DYRK4 | PTKHVQHSGDQQDCLQHGADtVQLPQLVDAPKKSEAAVGAE |
| Q9NR20 | T500 | Sugiyama | DYRK4 | PQLVDAPKKSEAAVGAEVsMtsPGQSKNFSLKNTNVLPPIV |
| Q9NR20 | Y264 | SIGNOR|PSP | DYRK4 | ASVKVIDFGSSCYEHQKVYTyIQSRFYRSPEVILGHPYDVA |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NXH9 | S524 | Sugiyama | TRMT1 | KECPVKRERLsETsPAFRILsVEPRLQANFTIREDANPSSR |
| Q9NY33 | S218 | Sugiyama | DPP3 | tRLFKEVDGEGKPYYEVRLAsVLGSEPsLDsEVTSKLKSYE |
| Q9UGV2 | S341 | Sugiyama | NDRG3 | MTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGtQESCEs |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UMZ2 | S1082 | Sugiyama | SYNRG AP1GBP1 SYNG | FDLSVQGSHKRsLsLGDKEIsRssPsPALEQPFRDRsNtLN |
| Q9UMZ2 | S1087 | Sugiyama | SYNRG AP1GBP1 SYNG | QGSHKRsLsLGDKEIsRssPsPALEQPFRDRsNtLNEKPAL |
| Q9UNX3 | S32 | Sugiyama | RPL26L1 RPL26P1 | sKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRKD |
| Q9UNZ2 | T73 | Sugiyama | NSFL1C UBXN2C | ISQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQR |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1318 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | VPsMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGP |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2398 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ANLtsPRVPLsAyERVsGRtsPPLLDRARsRtPPsAPsQsR |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9UQ35 | S322 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RRGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDK |
| Q9UQ35 | S377 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sstGPEPPAPtPLLAERHGGsPQPLAttPLsQEPVNPPsEA |
| Q9UQ35 | T328 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APFsEPGttstQRPssPEtAtKQPssPYEDKDKDKKEKsAt |
| Q9UQ35 | T383 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PPAPtPLLAERHGGsPQPLAttPLsQEPVNPPsEAsPtRDR |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y3D9 | T160 | Sugiyama | MRPS23 CGI-138 HSPC329 | TQHGGSHVSRKSEHLSVRPQtALEENETQKEVPQDQHLEAP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 4.366367e-08 | 7.360 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.329288e-08 | 7.273 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.316526e-07 | 6.881 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.195442e-06 | 5.495 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.578774e-05 | 4.802 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.802158e-05 | 4.744 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.815407e-05 | 4.550 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.913901e-05 | 4.160 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.030440e-04 | 3.987 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.198789e-04 | 3.921 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.178986e-04 | 3.928 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.398546e-04 | 3.854 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.587381e-04 | 3.799 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.901736e-04 | 3.721 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.901736e-04 | 3.721 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.011601e-04 | 3.696 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.912209e-04 | 3.536 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.965716e-04 | 3.528 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.732534e-04 | 3.428 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.049790e-04 | 3.393 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.465209e-04 | 3.350 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.736568e-04 | 3.241 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.736568e-04 | 3.241 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.631365e-04 | 3.178 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.432687e-04 | 3.129 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.640998e-04 | 3.117 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.590507e-04 | 3.120 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.300914e-04 | 3.137 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.011736e-04 | 3.096 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.393030e-04 | 3.076 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.209414e-04 | 3.036 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.273582e-04 | 3.033 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.151901e-03 | 2.939 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.398357e-03 | 2.854 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.429259e-03 | 2.845 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.700145e-03 | 2.770 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.893499e-03 | 2.723 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.944931e-03 | 2.711 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.054190e-03 | 2.687 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.145802e-03 | 2.668 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.151348e-03 | 2.667 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.029457e-03 | 2.693 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.611689e-03 | 2.583 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.716439e-03 | 2.566 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.211997e-03 | 2.493 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.419450e-03 | 2.466 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.939575e-03 | 2.532 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.149633e-03 | 2.502 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.774465e-03 | 2.423 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.181164e-03 | 2.379 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.217345e-03 | 2.375 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.452132e-03 | 2.351 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.709329e-03 | 2.327 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.496019e-03 | 2.347 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.920569e-03 | 2.308 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.090788e-03 | 2.293 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 5.593694e-03 | 2.252 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 5.593694e-03 | 2.252 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 5.593694e-03 | 2.252 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.861682e-03 | 2.232 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.334321e-03 | 2.273 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.682313e-03 | 2.245 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.197431e-03 | 2.208 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.357065e-03 | 2.197 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.989766e-03 | 2.156 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.439551e-03 | 2.128 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.439551e-03 | 2.128 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.716197e-03 | 2.113 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 9.350025e-03 | 2.029 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.350025e-03 | 2.029 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 9.350025e-03 | 2.029 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.350025e-03 | 2.029 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.343996e-03 | 2.029 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.014132e-03 | 2.045 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.950471e-03 | 2.002 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.032619e-02 | 1.986 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.146612e-02 | 1.941 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.146746e-02 | 1.941 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.216604e-02 | 1.915 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.250353e-02 | 1.903 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.233995e-02 | 1.909 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.309981e-02 | 1.883 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.250353e-02 | 1.903 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.284626e-02 | 1.891 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.317941e-02 | 1.880 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.325755e-02 | 1.878 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.345741e-02 | 1.871 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.544371e-02 | 1.811 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.544371e-02 | 1.811 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.484780e-02 | 1.828 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.581391e-02 | 1.801 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.488979e-02 | 1.827 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.589749e-02 | 1.799 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.589749e-02 | 1.799 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.606629e-02 | 1.794 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.875638e-02 | 1.727 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.788386e-02 | 1.748 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.672796e-02 | 1.777 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.672796e-02 | 1.777 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.678594e-02 | 1.775 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.875638e-02 | 1.727 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.674753e-02 | 1.776 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.704022e-02 | 1.769 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.882243e-02 | 1.725 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.976758e-02 | 1.704 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.976758e-02 | 1.704 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.046609e-02 | 1.689 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.053525e-02 | 1.687 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.155998e-02 | 1.666 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.358768e-02 | 1.627 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.358768e-02 | 1.627 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.358768e-02 | 1.627 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.358768e-02 | 1.627 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.358768e-02 | 1.627 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.309028e-02 | 1.637 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.170369e-02 | 1.663 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.320748e-02 | 1.634 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.231506e-02 | 1.651 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.437474e-02 | 1.613 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.489799e-02 | 1.604 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.607978e-02 | 1.584 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.607978e-02 | 1.584 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.607978e-02 | 1.584 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.607978e-02 | 1.584 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.628491e-02 | 1.580 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.869826e-02 | 1.542 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.869826e-02 | 1.542 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.818054e-02 | 1.550 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.628491e-02 | 1.580 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.869826e-02 | 1.542 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.877250e-02 | 1.541 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.907213e-02 | 1.537 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.950957e-02 | 1.530 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.002485e-02 | 1.523 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.002485e-02 | 1.523 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.018940e-02 | 1.520 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.029039e-02 | 1.519 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.148482e-02 | 1.502 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.148482e-02 | 1.502 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.148482e-02 | 1.502 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.355052e-02 | 1.474 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.231017e-02 | 1.491 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.231017e-02 | 1.491 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.285049e-02 | 1.483 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.336175e-02 | 1.477 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.449136e-02 | 1.462 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.336175e-02 | 1.477 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.462699e-02 | 1.461 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.514980e-02 | 1.454 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.545682e-02 | 1.450 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.605115e-02 | 1.443 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.702560e-02 | 1.431 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.215131e-02 | 1.375 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.856378e-02 | 1.414 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.960163e-02 | 1.402 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.774764e-02 | 1.423 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.066300e-02 | 1.391 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.066300e-02 | 1.391 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.032442e-02 | 1.394 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.222572e-02 | 1.374 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.222572e-02 | 1.374 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.222572e-02 | 1.374 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.222572e-02 | 1.374 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.222572e-02 | 1.374 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.222572e-02 | 1.374 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.222572e-02 | 1.374 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.253603e-02 | 1.371 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.299462e-02 | 1.367 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.374843e-02 | 1.359 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.628450e-02 | 1.335 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 4.917714e-02 | 1.308 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.917714e-02 | 1.308 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.991281e-02 | 1.302 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.052686e-02 | 1.296 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.053836e-02 | 1.296 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.053836e-02 | 1.296 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.628282e-02 | 1.250 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.198854e-02 | 1.284 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.713416e-02 | 1.243 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.151795e-02 | 1.288 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.316714e-02 | 1.274 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.213313e-02 | 1.283 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.503243e-02 | 1.259 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.461335e-02 | 1.263 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.787884e-02 | 1.237 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.866497e-02 | 1.232 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.248780e-02 | 1.204 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.328261e-02 | 1.199 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.333908e-02 | 1.198 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.547680e-02 | 1.184 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.644716e-02 | 1.178 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.884597e-02 | 1.162 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.937701e-02 | 1.159 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.937701e-02 | 1.159 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.937701e-02 | 1.159 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.937701e-02 | 1.159 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.937701e-02 | 1.159 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.026172e-02 | 1.153 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.107394e-02 | 1.091 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.566694e-02 | 1.121 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.566694e-02 | 1.121 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.727883e-02 | 1.112 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.073046e-02 | 1.093 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.073046e-02 | 1.093 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.141643e-02 | 1.089 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.107394e-02 | 1.091 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.400957e-02 | 1.131 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.951595e-02 | 1.100 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.310277e-02 | 1.136 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.566694e-02 | 1.121 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.300770e-02 | 1.137 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.726666e-02 | 1.112 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.162617e-02 | 1.088 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.262603e-02 | 1.083 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.431120e-02 | 1.129 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.281340e-02 | 1.138 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.309004e-02 | 1.080 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.432757e-02 | 1.074 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 8.479104e-02 | 1.072 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.904577e-02 | 1.050 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.926288e-02 | 1.049 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.926288e-02 | 1.049 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.926288e-02 | 1.049 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.926288e-02 | 1.049 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.926288e-02 | 1.049 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.926288e-02 | 1.049 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.089682e-02 | 1.041 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.089682e-02 | 1.041 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.089682e-02 | 1.041 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.151430e-02 | 1.039 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 1.107466e-01 | 0.956 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.107466e-01 | 0.956 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.107466e-01 | 0.956 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.107466e-01 | 0.956 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.107466e-01 | 0.956 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.023624e-01 | 0.990 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.040326e-01 | 0.983 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.040326e-01 | 0.983 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.040326e-01 | 0.983 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.087877e-01 | 0.963 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.373345e-02 | 1.028 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.373345e-02 | 1.028 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.018925e-01 | 0.992 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.078823e-01 | 0.967 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.011419e-01 | 0.995 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.767135e-02 | 1.010 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.087877e-01 | 0.963 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.087877e-01 | 0.963 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.087877e-01 | 0.963 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.103195e-01 | 0.957 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.032304e-01 | 0.986 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.284650e-02 | 1.032 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.087877e-01 | 0.963 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.087877e-01 | 0.963 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.821918e-02 | 1.008 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.094725e-01 | 0.961 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.284650e-02 | 1.032 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.032304e-01 | 0.986 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.001897e-01 | 0.999 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.696714e-02 | 1.013 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.040326e-01 | 0.983 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.142326e-01 | 0.942 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.148042e-01 | 0.940 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.148042e-01 | 0.940 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.148042e-01 | 0.940 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.148042e-01 | 0.940 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.148042e-01 | 0.940 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.148042e-01 | 0.940 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.148042e-01 | 0.940 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.170183e-01 | 0.932 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.175687e-01 | 0.930 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.175687e-01 | 0.930 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.175687e-01 | 0.930 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.175687e-01 | 0.930 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.175687e-01 | 0.930 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.092342e-01 | 0.679 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.092342e-01 | 0.679 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.572528e-01 | 0.803 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.572528e-01 | 0.803 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.572528e-01 | 0.803 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.572528e-01 | 0.803 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.572528e-01 | 0.803 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.968191e-01 | 0.528 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.968191e-01 | 0.528 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 2.968191e-01 | 0.528 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.968191e-01 | 0.528 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.968191e-01 | 0.528 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.968191e-01 | 0.528 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.968191e-01 | 0.528 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.968191e-01 | 0.528 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.968191e-01 | 0.528 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.968191e-01 | 0.528 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.968191e-01 | 0.528 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.989733e-01 | 0.701 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.989733e-01 | 0.701 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.989733e-01 | 0.701 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.989733e-01 | 0.701 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.989733e-01 | 0.701 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.214511e-01 | 0.916 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.214511e-01 | 0.916 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.214511e-01 | 0.916 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.214511e-01 | 0.916 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.684904e-01 | 0.773 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.684904e-01 | 0.773 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.684904e-01 | 0.773 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.417929e-01 | 0.617 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.417929e-01 | 0.617 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.417929e-01 | 0.617 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.417929e-01 | 0.617 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.417929e-01 | 0.617 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.417929e-01 | 0.617 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.747077e-01 | 0.426 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.747077e-01 | 0.426 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.747077e-01 | 0.426 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.747077e-01 | 0.426 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.747077e-01 | 0.426 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.747077e-01 | 0.426 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.747077e-01 | 0.426 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.747077e-01 | 0.426 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.747077e-01 | 0.426 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.747077e-01 | 0.426 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.419303e-01 | 0.848 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.419303e-01 | 0.848 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.419303e-01 | 0.848 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.976090e-01 | 0.704 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.636602e-01 | 0.786 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.636602e-01 | 0.786 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.849570e-01 | 0.545 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.849570e-01 | 0.545 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.368789e-01 | 0.864 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.278156e-01 | 0.642 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.278156e-01 | 0.642 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.278156e-01 | 0.642 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.864919e-01 | 0.729 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.864919e-01 | 0.729 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.548217e-01 | 0.810 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.736740e-01 | 0.760 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.736740e-01 | 0.760 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.736740e-01 | 0.760 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.736740e-01 | 0.760 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.736740e-01 | 0.760 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.736740e-01 | 0.760 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.588076e-01 | 0.587 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.588076e-01 | 0.587 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.588076e-01 | 0.587 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.588076e-01 | 0.587 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.278645e-01 | 0.484 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.278645e-01 | 0.484 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.278645e-01 | 0.484 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.278645e-01 | 0.484 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.278645e-01 | 0.484 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.439729e-01 | 0.353 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.439729e-01 | 0.353 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.439729e-01 | 0.353 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.439729e-01 | 0.353 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.439729e-01 | 0.353 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.439729e-01 | 0.353 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.352143e-01 | 0.869 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.610315e-01 | 0.793 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.933504e-01 | 0.714 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.903036e-01 | 0.537 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.952029e-01 | 0.710 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.952029e-01 | 0.710 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.952029e-01 | 0.710 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.600532e-01 | 0.585 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.700429e-01 | 0.432 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.700429e-01 | 0.432 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.700429e-01 | 0.432 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.700429e-01 | 0.432 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.348115e-01 | 0.629 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.132296e-01 | 0.671 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.132296e-01 | 0.671 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.220454e-01 | 0.492 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.220454e-01 | 0.492 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.944634e-01 | 0.711 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.857495e-01 | 0.544 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.857495e-01 | 0.544 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.734302e-01 | 0.761 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.784570e-01 | 0.555 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.117868e-01 | 0.506 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.117868e-01 | 0.506 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.538002e-01 | 0.451 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.111276e-01 | 0.386 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.111276e-01 | 0.386 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.111276e-01 | 0.386 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.111276e-01 | 0.386 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.055691e-01 | 0.296 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.055691e-01 | 0.296 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.055691e-01 | 0.296 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.055691e-01 | 0.296 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.055691e-01 | 0.296 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.856730e-01 | 0.731 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.222717e-01 | 0.653 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.703276e-01 | 0.568 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.703276e-01 | 0.568 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.636232e-01 | 0.786 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.380263e-01 | 0.471 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.853605e-01 | 0.414 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.853605e-01 | 0.414 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.840882e-01 | 0.735 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.235336e-01 | 0.490 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.508436e-01 | 0.346 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.508436e-01 | 0.346 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.165443e-01 | 0.380 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.164255e-01 | 0.500 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.164255e-01 | 0.500 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.164255e-01 | 0.500 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.164255e-01 | 0.500 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.917202e-01 | 0.535 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.917202e-01 | 0.535 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.693169e-01 | 0.433 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.693169e-01 | 0.433 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.510747e-01 | 0.455 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.550393e-01 | 0.593 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.537279e-01 | 0.451 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.537279e-01 | 0.451 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.537279e-01 | 0.451 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.889901e-01 | 0.311 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.603449e-01 | 0.252 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.603449e-01 | 0.252 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.603449e-01 | 0.252 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.603449e-01 | 0.252 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.425341e-01 | 0.354 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.425341e-01 | 0.354 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.425341e-01 | 0.354 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.914192e-01 | 0.407 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.680143e-01 | 0.330 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.254274e-01 | 0.279 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.291386e-01 | 0.367 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.291386e-01 | 0.367 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.291386e-01 | 0.367 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.250881e-01 | 0.372 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.063748e-01 | 0.296 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.479029e-01 | 0.349 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.930571e-01 | 0.307 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.740130e-01 | 0.324 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.665511e-01 | 0.331 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.347017e-01 | 0.272 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.347017e-01 | 0.272 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.600662e-01 | 0.252 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.600662e-01 | 0.252 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.600662e-01 | 0.252 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.446914e-01 | 0.264 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.568408e-01 | 0.254 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.572207e-01 | 0.254 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.884587e-01 | 0.230 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.884587e-01 | 0.230 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.875555e-01 | 0.231 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.875555e-01 | 0.231 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.881099e-01 | 0.231 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.020375e-01 | 0.396 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.175905e-01 | 0.286 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.151377e-01 | 0.382 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.409179e-01 | 0.467 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.643375e-01 | 0.438 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.643375e-01 | 0.438 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.776585e-01 | 0.238 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.836413e-01 | 0.416 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.419303e-01 | 0.848 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.441625e-01 | 0.612 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.600532e-01 | 0.585 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.600532e-01 | 0.585 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.404606e-01 | 0.468 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.727170e-01 | 0.325 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.245861e-01 | 0.649 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.164255e-01 | 0.500 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.940133e-01 | 0.306 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.281200e-01 | 0.277 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.800290e-01 | 0.237 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.800290e-01 | 0.237 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.508564e-01 | 0.601 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.905988e-01 | 0.408 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.206760e-01 | 0.656 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.458042e-01 | 0.263 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.195366e-01 | 0.922 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.355143e-01 | 0.271 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.875555e-01 | 0.231 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.450015e-01 | 0.839 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.600532e-01 | 0.585 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.380263e-01 | 0.471 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.483467e-01 | 0.605 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.693169e-01 | 0.433 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.903036e-01 | 0.537 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.636338e-01 | 0.786 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.324279e-01 | 0.274 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.659467e-01 | 0.247 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.875555e-01 | 0.231 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.164255e-01 | 0.500 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.245861e-01 | 0.649 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.222717e-01 | 0.653 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.771747e-01 | 0.321 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.890438e-01 | 0.539 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.378722e-01 | 0.359 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.881099e-01 | 0.231 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.510113e-01 | 0.346 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.557418e-01 | 0.449 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.976090e-01 | 0.704 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.220454e-01 | 0.492 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.778048e-01 | 0.750 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.620347e-01 | 0.582 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 5.415521e-01 | 0.266 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.684904e-01 | 0.773 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.864919e-01 | 0.729 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.380263e-01 | 0.471 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.102583e-01 | 0.508 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.508436e-01 | 0.346 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.508436e-01 | 0.346 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.980383e-01 | 0.526 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.866985e-01 | 0.729 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.905988e-01 | 0.408 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.889901e-01 | 0.311 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.725480e-01 | 0.429 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.063748e-01 | 0.296 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.489454e-01 | 0.260 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.836413e-01 | 0.416 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.214511e-01 | 0.916 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.636602e-01 | 0.786 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.111276e-01 | 0.386 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.261381e-01 | 0.279 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.415521e-01 | 0.266 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.161657e-01 | 0.665 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.445157e-01 | 0.612 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.853605e-01 | 0.414 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.857495e-01 | 0.544 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.632733e-01 | 0.787 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.632733e-01 | 0.787 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.445157e-01 | 0.612 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.132754e-01 | 0.671 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.214511e-01 | 0.916 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.491047e-01 | 0.827 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.700429e-01 | 0.432 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.787663e-01 | 0.748 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.564086e-01 | 0.591 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.111276e-01 | 0.386 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.055691e-01 | 0.296 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 3.853605e-01 | 0.414 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.818166e-01 | 0.740 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.425341e-01 | 0.354 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.425511e-01 | 0.354 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.875555e-01 | 0.231 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.897630e-01 | 0.722 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.128643e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.222717e-01 | 0.653 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.441334e-01 | 0.841 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.875555e-01 | 0.231 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.553728e-01 | 0.449 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.390071e-01 | 0.857 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.249029e-01 | 0.903 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.103813e-01 | 0.677 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.391372e-01 | 0.857 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.886675e-01 | 0.410 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.886675e-01 | 0.410 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.273834e-01 | 0.278 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.600662e-01 | 0.252 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.800290e-01 | 0.237 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.771019e-01 | 0.239 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.522952e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.737064e-01 | 0.760 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.643375e-01 | 0.438 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.661231e-01 | 0.575 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.419303e-01 | 0.848 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.937926e-01 | 0.532 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.989733e-01 | 0.701 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.989733e-01 | 0.701 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.368789e-01 | 0.864 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.368789e-01 | 0.864 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.297451e-01 | 0.887 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.736740e-01 | 0.760 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.348435e-01 | 0.629 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.508018e-01 | 0.822 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.348115e-01 | 0.629 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.212109e-01 | 0.655 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.603449e-01 | 0.252 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.603449e-01 | 0.252 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.603449e-01 | 0.252 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.699485e-01 | 0.432 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.884587e-01 | 0.230 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.106002e-01 | 0.387 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.082801e-01 | 0.294 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.352143e-01 | 0.869 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.665511e-01 | 0.331 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.378053e-01 | 0.861 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.102583e-01 | 0.508 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.917959e-01 | 0.535 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.588076e-01 | 0.587 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.194706e-01 | 0.923 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.096162e-01 | 0.679 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.696556e-01 | 0.770 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.807688e-01 | 0.552 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.807688e-01 | 0.552 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.807688e-01 | 0.552 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.807688e-01 | 0.552 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.976090e-01 | 0.704 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.223857e-01 | 0.912 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.777838e-01 | 0.750 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.771019e-01 | 0.239 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.926690e-01 | 0.534 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.572528e-01 | 0.803 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.278156e-01 | 0.642 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.278645e-01 | 0.484 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.439729e-01 | 0.353 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.348115e-01 | 0.629 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.055691e-01 | 0.296 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.055691e-01 | 0.296 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.112710e-01 | 0.675 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.508436e-01 | 0.346 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.458400e-01 | 0.836 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.165443e-01 | 0.380 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.884019e-01 | 0.411 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.254274e-01 | 0.279 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.559176e-01 | 0.341 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.622894e-01 | 0.335 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.252970e-01 | 0.488 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.252970e-01 | 0.488 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.703276e-01 | 0.568 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.102243e-01 | 0.387 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.973189e-01 | 0.705 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.446648e-01 | 0.463 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.849570e-01 | 0.545 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.219944e-01 | 0.914 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 5.055691e-01 | 0.296 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.254274e-01 | 0.279 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.940133e-01 | 0.306 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.893802e-01 | 0.310 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.696556e-01 | 0.770 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.680143e-01 | 0.330 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.278645e-01 | 0.484 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.570739e-01 | 0.590 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.771747e-01 | 0.321 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.347017e-01 | 0.272 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.448729e-01 | 0.839 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.042269e-01 | 0.517 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.406269e-01 | 0.267 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.275192e-01 | 0.643 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.348435e-01 | 0.629 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.980714e-01 | 0.703 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.063748e-01 | 0.296 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.168343e-01 | 0.664 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.042269e-01 | 0.517 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.367234e-01 | 0.473 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.222717e-01 | 0.653 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.371478e-01 | 0.270 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.381541e-01 | 0.358 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.922701e-01 | 0.716 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.367234e-01 | 0.473 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.118152e-01 | 0.674 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.856479e-01 | 0.232 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.725480e-01 | 0.429 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.350046e-01 | 0.475 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.092342e-01 | 0.679 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.572528e-01 | 0.803 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.968191e-01 | 0.528 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.989733e-01 | 0.701 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.989733e-01 | 0.701 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.747077e-01 | 0.426 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 3.747077e-01 | 0.426 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.747077e-01 | 0.426 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.849570e-01 | 0.545 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.864919e-01 | 0.729 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.219944e-01 | 0.914 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.450015e-01 | 0.839 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.450015e-01 | 0.839 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.102716e-01 | 0.677 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.777838e-01 | 0.750 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.700429e-01 | 0.432 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.857495e-01 | 0.544 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.111276e-01 | 0.386 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.055691e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.055691e-01 | 0.296 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.538520e-01 | 0.595 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.235336e-01 | 0.490 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.196085e-01 | 0.922 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.508436e-01 | 0.346 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.471938e-01 | 0.350 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.603449e-01 | 0.252 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.603449e-01 | 0.252 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.771747e-01 | 0.321 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.254274e-01 | 0.279 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.063748e-01 | 0.296 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.788009e-01 | 0.422 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.347017e-01 | 0.272 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.600662e-01 | 0.252 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.863984e-01 | 0.313 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.261381e-01 | 0.279 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.331908e-01 | 0.273 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.392799e-01 | 0.268 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.446914e-01 | 0.264 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.541086e-01 | 0.256 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.398053e-01 | 0.620 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.789966e-01 | 0.554 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.699485e-01 | 0.432 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.097803e-01 | 0.678 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.504244e-01 | 0.455 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.261381e-01 | 0.279 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.177594e-01 | 0.662 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.035487e-01 | 0.518 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.386651e-01 | 0.470 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.177594e-01 | 0.662 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.177594e-01 | 0.662 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.584288e-01 | 0.339 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.869741e-01 | 0.542 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.952029e-01 | 0.710 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.736740e-01 | 0.760 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.538520e-01 | 0.595 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.366325e-01 | 0.864 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.445157e-01 | 0.612 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.747153e-01 | 0.561 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.955285e-01 | 0.709 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.377388e-01 | 0.471 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.348115e-01 | 0.629 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.508436e-01 | 0.346 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.981367e-01 | 0.400 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.955285e-01 | 0.709 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.534677e-01 | 0.814 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.137605e-01 | 0.670 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.797069e-01 | 0.237 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.988990e-01 | 0.399 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.278645e-01 | 0.484 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.508436e-01 | 0.346 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.720266e-01 | 0.429 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.781655e-01 | 0.422 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.261381e-01 | 0.279 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.234065e-01 | 0.490 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.903036e-01 | 0.537 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.111276e-01 | 0.386 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.779457e-01 | 0.750 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.976090e-01 | 0.704 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.680143e-01 | 0.330 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.539638e-01 | 0.343 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.033540e-01 | 0.298 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.033540e-01 | 0.298 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.188445e-01 | 0.496 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.857495e-01 | 0.544 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.610315e-01 | 0.793 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.643375e-01 | 0.438 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.801141e-01 | 0.319 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.832229e-01 | 0.737 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.477384e-01 | 0.459 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.417929e-01 | 0.617 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.787663e-01 | 0.748 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.787663e-01 | 0.748 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.055691e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.807688e-01 | 0.552 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.471938e-01 | 0.350 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.889901e-01 | 0.311 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.603449e-01 | 0.252 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.254274e-01 | 0.279 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.720708e-01 | 0.429 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.139998e-01 | 0.383 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.045849e-01 | 0.297 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.568408e-01 | 0.254 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.905988e-01 | 0.408 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.930571e-01 | 0.307 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.407790e-01 | 0.851 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.684904e-01 | 0.773 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.864919e-01 | 0.729 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.610121e-01 | 0.583 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.922766e-01 | 0.406 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.251949e-01 | 0.647 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.684904e-01 | 0.773 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.849570e-01 | 0.545 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.849570e-01 | 0.545 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.853605e-01 | 0.414 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.842769e-01 | 0.546 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.695842e-01 | 0.771 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.710341e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.944137e-01 | 0.306 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.703972e-01 | 0.769 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.199254e-01 | 0.921 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.943569e-01 | 0.306 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.735359e-01 | 0.563 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.298230e-01 | 0.482 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.102716e-01 | 0.677 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.278645e-01 | 0.484 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.600532e-01 | 0.585 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.111276e-01 | 0.386 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.055691e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.603449e-01 | 0.252 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.603449e-01 | 0.252 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.603449e-01 | 0.252 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 5.254274e-01 | 0.279 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.403249e-01 | 0.853 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.212272e-01 | 0.375 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.415521e-01 | 0.266 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.632733e-01 | 0.787 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.165443e-01 | 0.380 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.347017e-01 | 0.272 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.434279e-01 | 0.353 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.620819e-01 | 0.250 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.696556e-01 | 0.770 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.102583e-01 | 0.508 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.382692e-01 | 0.623 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.272256e-01 | 0.485 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.889901e-01 | 0.311 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.903036e-01 | 0.537 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.903036e-01 | 0.537 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.903036e-01 | 0.537 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.662350e-01 | 0.779 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 3.538002e-01 | 0.451 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.175905e-01 | 0.286 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.704611e-01 | 0.327 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.889901e-01 | 0.311 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.603449e-01 | 0.252 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.592027e-01 | 0.338 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.063748e-01 | 0.296 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.772155e-01 | 0.321 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.710341e-01 | 0.243 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.893797e-01 | 0.230 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.893797e-01 | 0.230 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.893797e-01 | 0.230 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.893797e-01 | 0.230 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.909664e-01 | 0.228 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.928578e-01 | 0.227 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.928578e-01 | 0.227 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.928578e-01 | 0.227 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.928578e-01 | 0.227 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.032391e-01 | 0.220 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.077551e-01 | 0.216 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.084062e-01 | 0.216 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.090552e-01 | 0.215 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.090552e-01 | 0.215 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.090552e-01 | 0.215 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.090552e-01 | 0.215 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.090552e-01 | 0.215 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.090552e-01 | 0.215 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.090552e-01 | 0.215 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.090552e-01 | 0.215 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.090552e-01 | 0.215 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.090552e-01 | 0.215 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.090552e-01 | 0.215 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.090552e-01 | 0.215 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.090552e-01 | 0.215 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.090552e-01 | 0.215 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.090552e-01 | 0.215 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 6.090552e-01 | 0.215 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.090552e-01 | 0.215 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.090552e-01 | 0.215 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.090552e-01 | 0.215 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.090552e-01 | 0.215 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.093322e-01 | 0.215 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.095163e-01 | 0.215 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.095163e-01 | 0.215 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.095163e-01 | 0.215 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.107904e-01 | 0.214 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.137497e-01 | 0.212 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.137907e-01 | 0.212 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.137907e-01 | 0.212 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.137907e-01 | 0.212 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.137907e-01 | 0.212 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.137907e-01 | 0.212 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.154654e-01 | 0.211 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.199548e-01 | 0.208 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.237863e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.237863e-01 | 0.205 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.237863e-01 | 0.205 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.237863e-01 | 0.205 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.237863e-01 | 0.205 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.238460e-01 | 0.205 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.247964e-01 | 0.204 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.249744e-01 | 0.204 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.268486e-01 | 0.203 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.307424e-01 | 0.200 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.310534e-01 | 0.200 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.324170e-01 | 0.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.377491e-01 | 0.195 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.378868e-01 | 0.195 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.380497e-01 | 0.195 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.380497e-01 | 0.195 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.380497e-01 | 0.195 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.396917e-01 | 0.194 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.418283e-01 | 0.193 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.418283e-01 | 0.193 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.418283e-01 | 0.193 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.453698e-01 | 0.190 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.453698e-01 | 0.190 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.453698e-01 | 0.190 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.457501e-01 | 0.190 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.508447e-01 | 0.187 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.512119e-01 | 0.186 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.523713e-01 | 0.186 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.523713e-01 | 0.186 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.523713e-01 | 0.186 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.523713e-01 | 0.186 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.523713e-01 | 0.186 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.523713e-01 | 0.186 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.523713e-01 | 0.186 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.523713e-01 | 0.186 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.523713e-01 | 0.186 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.528619e-01 | 0.185 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.528619e-01 | 0.185 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.528619e-01 | 0.185 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.528619e-01 | 0.185 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.528619e-01 | 0.185 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.528619e-01 | 0.185 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.528619e-01 | 0.185 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.528619e-01 | 0.185 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.528619e-01 | 0.185 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.528619e-01 | 0.185 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.528619e-01 | 0.185 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.528619e-01 | 0.185 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.530106e-01 | 0.185 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.612196e-01 | 0.180 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.612196e-01 | 0.180 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.612196e-01 | 0.180 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.633027e-01 | 0.178 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.709095e-01 | 0.173 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.724326e-01 | 0.172 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.724326e-01 | 0.172 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.724326e-01 | 0.172 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.744634e-01 | 0.171 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.744634e-01 | 0.171 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.762254e-01 | 0.170 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.782588e-01 | 0.169 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.801155e-01 | 0.167 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.801155e-01 | 0.167 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.806350e-01 | 0.167 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.806350e-01 | 0.167 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.806350e-01 | 0.167 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.832946e-01 | 0.165 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.832946e-01 | 0.165 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.884964e-01 | 0.162 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.898260e-01 | 0.161 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.898260e-01 | 0.161 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.908903e-01 | 0.161 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.908903e-01 | 0.161 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.908903e-01 | 0.161 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.908903e-01 | 0.161 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.908903e-01 | 0.161 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.908903e-01 | 0.161 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.908903e-01 | 0.161 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.908903e-01 | 0.161 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.908903e-01 | 0.161 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.908903e-01 | 0.161 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.908903e-01 | 0.161 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.908903e-01 | 0.161 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.945116e-01 | 0.158 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.973583e-01 | 0.157 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.973583e-01 | 0.157 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.990433e-01 | 0.155 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.004801e-01 | 0.155 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.036015e-01 | 0.153 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.042781e-01 | 0.152 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.042781e-01 | 0.152 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.042781e-01 | 0.152 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.042781e-01 | 0.152 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.051255e-01 | 0.152 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.051738e-01 | 0.152 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.055940e-01 | 0.151 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.055940e-01 | 0.151 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.055940e-01 | 0.151 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.055940e-01 | 0.151 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.055940e-01 | 0.151 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.055940e-01 | 0.151 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.055940e-01 | 0.151 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.055940e-01 | 0.151 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.076175e-01 | 0.150 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.079572e-01 | 0.150 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.079572e-01 | 0.150 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.095060e-01 | 0.149 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.128310e-01 | 0.147 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.197007e-01 | 0.143 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.241809e-01 | 0.140 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.241809e-01 | 0.140 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.241809e-01 | 0.140 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.251432e-01 | 0.140 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.251432e-01 | 0.140 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.251432e-01 | 0.140 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.251432e-01 | 0.140 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.251432e-01 | 0.140 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.251432e-01 | 0.140 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.251432e-01 | 0.140 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.251432e-01 | 0.140 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.251432e-01 | 0.140 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.251432e-01 | 0.140 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.251432e-01 | 0.140 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.251432e-01 | 0.140 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.251432e-01 | 0.140 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.251432e-01 | 0.140 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.251432e-01 | 0.140 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.251432e-01 | 0.140 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.251432e-01 | 0.140 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.251432e-01 | 0.140 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.253039e-01 | 0.139 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.253039e-01 | 0.139 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.253039e-01 | 0.139 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.253039e-01 | 0.139 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.253039e-01 | 0.139 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.261881e-01 | 0.139 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.261881e-01 | 0.139 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.268881e-01 | 0.139 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.279807e-01 | 0.138 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.289605e-01 | 0.137 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.293559e-01 | 0.137 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.293559e-01 | 0.137 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.293559e-01 | 0.137 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.310206e-01 | 0.136 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.332790e-01 | 0.135 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.332790e-01 | 0.135 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.337680e-01 | 0.134 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.378847e-01 | 0.132 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.391520e-01 | 0.131 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.418709e-01 | 0.130 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.418709e-01 | 0.130 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.418709e-01 | 0.130 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.430206e-01 | 0.129 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.430206e-01 | 0.129 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.430206e-01 | 0.129 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.430206e-01 | 0.129 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.438387e-01 | 0.129 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.438387e-01 | 0.129 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.438387e-01 | 0.129 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.454614e-01 | 0.128 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.473270e-01 | 0.126 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.514687e-01 | 0.124 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.514687e-01 | 0.124 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.514687e-01 | 0.124 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.553943e-01 | 0.122 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.556022e-01 | 0.122 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.556022e-01 | 0.122 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.556022e-01 | 0.122 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.556022e-01 | 0.122 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.556022e-01 | 0.122 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.556022e-01 | 0.122 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.556022e-01 | 0.122 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.556022e-01 | 0.122 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.556022e-01 | 0.122 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.556022e-01 | 0.122 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.556022e-01 | 0.122 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.556022e-01 | 0.122 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.556022e-01 | 0.122 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.556022e-01 | 0.122 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.559558e-01 | 0.122 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.576670e-01 | 0.121 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.581053e-01 | 0.120 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.603794e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.603794e-01 | 0.119 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.603794e-01 | 0.119 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.608200e-01 | 0.119 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.615028e-01 | 0.118 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.720062e-01 | 0.112 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.720062e-01 | 0.112 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.720062e-01 | 0.112 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.720062e-01 | 0.112 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.720062e-01 | 0.112 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.720062e-01 | 0.112 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.720062e-01 | 0.112 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.720062e-01 | 0.112 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.727039e-01 | 0.112 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.727039e-01 | 0.112 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.741908e-01 | 0.111 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.776065e-01 | 0.109 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.776065e-01 | 0.109 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.826875e-01 | 0.106 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.826875e-01 | 0.106 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.826875e-01 | 0.106 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.826875e-01 | 0.106 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.826875e-01 | 0.106 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.826875e-01 | 0.106 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.826875e-01 | 0.106 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.826875e-01 | 0.106 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.826875e-01 | 0.106 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.826875e-01 | 0.106 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.826875e-01 | 0.106 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.838045e-01 | 0.106 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.840120e-01 | 0.106 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.856253e-01 | 0.105 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.869965e-01 | 0.104 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.903766e-01 | 0.102 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.910458e-01 | 0.102 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.910458e-01 | 0.102 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.934110e-01 | 0.101 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.945556e-01 | 0.100 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.005618e-01 | 0.097 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.005618e-01 | 0.097 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.005618e-01 | 0.097 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.039031e-01 | 0.095 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.064589e-01 | 0.093 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.064900e-01 | 0.093 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.067725e-01 | 0.093 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.067725e-01 | 0.093 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.067725e-01 | 0.093 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.067725e-01 | 0.093 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.067725e-01 | 0.093 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.067725e-01 | 0.093 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.067725e-01 | 0.093 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.067725e-01 | 0.093 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.076214e-01 | 0.093 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.082672e-01 | 0.092 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.082672e-01 | 0.092 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.086672e-01 | 0.092 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.086672e-01 | 0.092 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.086672e-01 | 0.092 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.086672e-01 | 0.092 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.086672e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.092058e-01 | 0.092 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.094447e-01 | 0.092 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.128852e-01 | 0.090 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.134188e-01 | 0.090 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.134188e-01 | 0.090 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.175675e-01 | 0.087 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.192596e-01 | 0.087 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.195168e-01 | 0.086 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.195541e-01 | 0.086 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.205420e-01 | 0.086 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.205420e-01 | 0.086 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.222110e-01 | 0.085 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.222110e-01 | 0.085 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.222110e-01 | 0.085 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.249508e-01 | 0.084 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.249508e-01 | 0.084 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.249508e-01 | 0.084 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.255883e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.255883e-01 | 0.083 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.255883e-01 | 0.083 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.255883e-01 | 0.083 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.281893e-01 | 0.082 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.281893e-01 | 0.082 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.281893e-01 | 0.082 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.281893e-01 | 0.082 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.281893e-01 | 0.082 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.281893e-01 | 0.082 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.281893e-01 | 0.082 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.297754e-01 | 0.081 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.352797e-01 | 0.078 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.352797e-01 | 0.078 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.352797e-01 | 0.078 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.352797e-01 | 0.078 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.361822e-01 | 0.078 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.362528e-01 | 0.078 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.370922e-01 | 0.077 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.380120e-01 | 0.077 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.389415e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.399767e-01 | 0.076 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.399767e-01 | 0.076 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.399767e-01 | 0.076 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.399767e-01 | 0.076 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.399767e-01 | 0.076 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.399767e-01 | 0.076 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.399767e-01 | 0.076 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.415811e-01 | 0.075 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.450081e-01 | 0.073 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.455567e-01 | 0.073 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.472335e-01 | 0.072 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.472335e-01 | 0.072 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.472335e-01 | 0.072 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.472335e-01 | 0.072 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.472335e-01 | 0.072 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.472335e-01 | 0.072 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.472335e-01 | 0.072 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.472335e-01 | 0.072 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.472335e-01 | 0.072 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.472335e-01 | 0.072 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.475116e-01 | 0.072 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.475116e-01 | 0.072 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.475116e-01 | 0.072 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.502563e-01 | 0.070 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.533835e-01 | 0.069 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.538235e-01 | 0.069 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.538235e-01 | 0.069 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.538235e-01 | 0.069 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.538235e-01 | 0.069 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.580514e-01 | 0.066 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.581960e-01 | 0.066 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.581960e-01 | 0.066 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.581960e-01 | 0.066 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.589455e-01 | 0.066 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.589455e-01 | 0.066 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.589455e-01 | 0.066 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.589455e-01 | 0.066 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.589455e-01 | 0.066 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.641677e-01 | 0.063 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.641677e-01 | 0.063 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.641677e-01 | 0.063 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.641677e-01 | 0.063 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.641677e-01 | 0.063 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.641677e-01 | 0.063 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.641677e-01 | 0.063 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.641677e-01 | 0.063 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.641677e-01 | 0.063 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.641677e-01 | 0.063 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.665679e-01 | 0.062 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.665679e-01 | 0.062 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.665679e-01 | 0.062 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.665679e-01 | 0.062 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.665679e-01 | 0.062 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.678440e-01 | 0.062 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.678440e-01 | 0.062 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.678440e-01 | 0.062 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.678440e-01 | 0.062 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.681218e-01 | 0.061 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.696204e-01 | 0.061 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.696204e-01 | 0.061 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.696204e-01 | 0.061 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.696204e-01 | 0.061 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.715731e-01 | 0.060 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.737061e-01 | 0.059 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.769221e-01 | 0.057 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.779548e-01 | 0.057 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.779548e-01 | 0.057 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.782842e-01 | 0.056 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.782842e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.782842e-01 | 0.056 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.782842e-01 | 0.056 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.782842e-01 | 0.056 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.792257e-01 | 0.056 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.792257e-01 | 0.056 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.792257e-01 | 0.056 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.792257e-01 | 0.056 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.792257e-01 | 0.056 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.792257e-01 | 0.056 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.792257e-01 | 0.056 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.792257e-01 | 0.056 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.795750e-01 | 0.056 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.795750e-01 | 0.056 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.795750e-01 | 0.056 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.798770e-01 | 0.056 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.853959e-01 | 0.053 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.871418e-01 | 0.052 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.888476e-01 | 0.051 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.888476e-01 | 0.051 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.888476e-01 | 0.051 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.890436e-01 | 0.051 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.890436e-01 | 0.051 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.890436e-01 | 0.051 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.890436e-01 | 0.051 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.890436e-01 | 0.051 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.899025e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.912095e-01 | 0.050 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.926151e-01 | 0.049 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.926151e-01 | 0.049 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.926151e-01 | 0.049 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.926151e-01 | 0.049 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.926151e-01 | 0.049 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.926151e-01 | 0.049 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.926151e-01 | 0.049 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.926151e-01 | 0.049 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.927896e-01 | 0.049 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.939633e-01 | 0.049 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.939633e-01 | 0.049 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.974757e-01 | 0.047 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.974757e-01 | 0.047 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.974757e-01 | 0.047 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.989142e-01 | 0.046 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.989142e-01 | 0.046 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.989142e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.989142e-01 | 0.046 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.989142e-01 | 0.046 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.989142e-01 | 0.046 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.004296e-01 | 0.046 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.009823e-01 | 0.045 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.009823e-01 | 0.045 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.045209e-01 | 0.044 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.045209e-01 | 0.044 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.045209e-01 | 0.044 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.045209e-01 | 0.044 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.045209e-01 | 0.044 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.045209e-01 | 0.044 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.045209e-01 | 0.044 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.045209e-01 | 0.044 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.045209e-01 | 0.044 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.045209e-01 | 0.044 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.054959e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.054959e-01 | 0.043 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.054959e-01 | 0.043 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.063481e-01 | 0.043 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.074810e-01 | 0.042 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.079608e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.079608e-01 | 0.042 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.079608e-01 | 0.042 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.079608e-01 | 0.042 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.084157e-01 | 0.042 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.099480e-01 | 0.041 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.129438e-01 | 0.040 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.129438e-01 | 0.040 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.146205e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.151073e-01 | 0.039 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.151073e-01 | 0.039 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.151073e-01 | 0.039 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.151073e-01 | 0.039 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.151073e-01 | 0.039 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.151073e-01 | 0.039 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.151073e-01 | 0.039 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.151073e-01 | 0.039 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.151073e-01 | 0.039 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.151073e-01 | 0.039 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.151073e-01 | 0.039 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.153370e-01 | 0.038 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.155718e-01 | 0.038 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.162448e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.162448e-01 | 0.038 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.162448e-01 | 0.038 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.162448e-01 | 0.038 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.162448e-01 | 0.038 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.162448e-01 | 0.038 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.198065e-01 | 0.036 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.198538e-01 | 0.036 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.207897e-01 | 0.036 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.207897e-01 | 0.036 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.216480e-01 | 0.035 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.238239e-01 | 0.034 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.238431e-01 | 0.034 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.238732e-01 | 0.034 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.245204e-01 | 0.034 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.245204e-01 | 0.034 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.245204e-01 | 0.034 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.245204e-01 | 0.034 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.245204e-01 | 0.034 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.245204e-01 | 0.034 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.262590e-01 | 0.033 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.265560e-01 | 0.033 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.265560e-01 | 0.033 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.265560e-01 | 0.033 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.279037e-01 | 0.032 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.294317e-01 | 0.032 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.300830e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.307526e-01 | 0.031 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.319411e-01 | 0.031 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.321388e-01 | 0.031 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.321912e-01 | 0.030 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.328466e-01 | 0.030 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.328903e-01 | 0.030 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.328903e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.328903e-01 | 0.030 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.328903e-01 | 0.030 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.328903e-01 | 0.030 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.328903e-01 | 0.030 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.338778e-01 | 0.030 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.353319e-01 | 0.029 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.368706e-01 | 0.028 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.376808e-01 | 0.028 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.376808e-01 | 0.028 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.403325e-01 | 0.027 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.403325e-01 | 0.027 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.403325e-01 | 0.027 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.403325e-01 | 0.027 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.403325e-01 | 0.027 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.403325e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.403325e-01 | 0.027 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.411311e-01 | 0.026 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.416520e-01 | 0.026 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.427568e-01 | 0.026 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.427568e-01 | 0.026 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.428597e-01 | 0.026 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.448320e-01 | 0.025 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.448320e-01 | 0.025 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.460178e-01 | 0.024 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.469498e-01 | 0.024 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.469498e-01 | 0.024 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.469498e-01 | 0.024 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.469498e-01 | 0.024 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.469498e-01 | 0.024 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.472727e-01 | 0.024 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.472951e-01 | 0.024 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.474467e-01 | 0.023 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.474467e-01 | 0.023 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.476493e-01 | 0.023 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.481302e-01 | 0.023 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.481302e-01 | 0.023 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.481302e-01 | 0.023 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.500826e-01 | 0.022 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.517769e-01 | 0.021 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.528335e-01 | 0.021 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.528335e-01 | 0.021 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.528335e-01 | 0.021 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.528335e-01 | 0.021 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.528335e-01 | 0.021 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.529348e-01 | 0.021 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.529348e-01 | 0.021 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.529348e-01 | 0.021 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.538645e-01 | 0.021 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.538645e-01 | 0.021 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.550928e-01 | 0.020 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.557720e-01 | 0.020 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.572026e-01 | 0.019 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.573808e-01 | 0.019 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.580650e-01 | 0.019 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.580650e-01 | 0.019 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.580650e-01 | 0.019 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.588026e-01 | 0.018 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.589770e-01 | 0.018 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.606479e-01 | 0.017 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.606479e-01 | 0.017 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.609015e-01 | 0.017 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.612979e-01 | 0.017 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.627165e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.627165e-01 | 0.017 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.627165e-01 | 0.017 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.627165e-01 | 0.017 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.627165e-01 | 0.017 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.635946e-01 | 0.016 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.636815e-01 | 0.016 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.649249e-01 | 0.016 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.668523e-01 | 0.015 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.668523e-01 | 0.015 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.668523e-01 | 0.015 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.668523e-01 | 0.015 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.695675e-01 | 0.013 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.712226e-01 | 0.013 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.714953e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.714953e-01 | 0.013 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.726465e-01 | 0.012 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.727626e-01 | 0.012 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.737990e-01 | 0.012 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.737990e-01 | 0.012 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.737990e-01 | 0.012 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.737990e-01 | 0.012 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.737990e-01 | 0.012 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.737990e-01 | 0.012 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.737990e-01 | 0.012 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.737990e-01 | 0.012 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.739474e-01 | 0.011 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.745594e-01 | 0.011 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.758433e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.758433e-01 | 0.011 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.758433e-01 | 0.011 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.764220e-01 | 0.010 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.764220e-01 | 0.010 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.764220e-01 | 0.010 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.767060e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.767060e-01 | 0.010 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.767060e-01 | 0.010 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.767060e-01 | 0.010 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.771601e-01 | 0.010 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.771601e-01 | 0.010 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.777633e-01 | 0.010 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.782105e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.786684e-01 | 0.009 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.786684e-01 | 0.009 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.792906e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.792906e-01 | 0.009 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.792906e-01 | 0.009 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.792906e-01 | 0.009 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.792906e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.792906e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.795806e-01 | 0.009 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.800923e-01 | 0.009 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.807068e-01 | 0.008 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.807068e-01 | 0.008 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.810256e-01 | 0.008 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.810977e-01 | 0.008 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.815885e-01 | 0.008 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.815885e-01 | 0.008 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.825556e-01 | 0.008 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.836316e-01 | 0.007 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.836316e-01 | 0.007 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.847717e-01 | 0.007 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.848493e-01 | 0.007 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.850681e-01 | 0.007 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.859247e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.861792e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.861792e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.866776e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.867367e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.867367e-01 | 0.006 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.870630e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.870630e-01 | 0.006 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.871272e-01 | 0.006 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.871272e-01 | 0.006 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.873951e-01 | 0.006 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.875857e-01 | 0.005 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.876790e-01 | 0.005 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.883736e-01 | 0.005 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.883736e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.884989e-01 | 0.005 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.884989e-01 | 0.005 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.885079e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.885079e-01 | 0.005 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.888756e-01 | 0.005 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.892701e-01 | 0.005 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.894541e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.895020e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.895020e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.896251e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.897754e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.897754e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.898878e-01 | 0.004 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.901013e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.902619e-01 | 0.004 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.902619e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.905232e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.909103e-01 | 0.004 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.911339e-01 | 0.004 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.913072e-01 | 0.004 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.919194e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.919194e-01 | 0.004 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.919194e-01 | 0.004 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.922828e-01 | 0.003 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.922828e-01 | 0.003 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.922828e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.923839e-01 | 0.003 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.926810e-01 | 0.003 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.926810e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.927942e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.928164e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.928164e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.928164e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.929874e-01 | 0.003 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.934423e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.934989e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.935451e-01 | 0.003 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.936139e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.936139e-01 | 0.003 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.936139e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.936139e-01 | 0.003 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.937399e-01 | 0.003 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.940118e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.943229e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.943229e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.943229e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.943386e-01 | 0.002 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.943732e-01 | 0.002 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.946905e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.946905e-01 | 0.002 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.946905e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.949533e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.949533e-01 | 0.002 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.949533e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.949533e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.950653e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.950653e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.950653e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.953998e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.955137e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.955137e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.955137e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.957539e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.958546e-01 | 0.002 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.960119e-01 | 0.002 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.960119e-01 | 0.002 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.960591e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.963816e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.964160e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.966347e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.966355e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.968485e-01 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.969392e-01 | 0.001 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.969437e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.969698e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.969698e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.970025e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.971428e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.971985e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.971985e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.972714e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.974810e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.975097e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.975298e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.977863e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.977863e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.977863e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.979341e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.979719e-01 | 0.001 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.980097e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.980322e-01 | 0.001 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.981359e-01 | 0.001 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.983504e-01 | 0.001 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.983504e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.984451e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.985503e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.986179e-01 | 0.001 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.986961e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.987715e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.987715e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.987785e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989080e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.989455e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990293e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.990520e-01 | 0.000 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.991372e-01 | 0.000 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.991478e-01 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.991675e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.992042e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992340e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.992553e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.993116e-01 | 0.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.993190e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.993190e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.993814e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.993941e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.993941e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.994245e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.994616e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.995213e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.995515e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.995515e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.995515e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.995745e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995972e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.996145e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.996354e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.996514e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.996639e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.996848e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997012e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997191e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997424e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997902e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998476e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998527e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998559e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.998632e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998632e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998683e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998691e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.998705e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998794e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.998885e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.999013e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.999070e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999081e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999081e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999183e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999183e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.999206e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.999236e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999245e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.999487e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999592e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999668e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999669e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999718e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999718e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999730e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999734e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.999743e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999787e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999801e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999822e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999859e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999861e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999899e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999912e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999921e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999944e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999952e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999952e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999954e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999954e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999966e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999987e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999990e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999992e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999993e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999994e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999995e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999995e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999998e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999999e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999999e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999999e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 1.744102e-08 | 7.758 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.149369e-08 | 7.668 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.396643e-07 | 6.027 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.131244e-06 | 5.039 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.660510e-05 | 4.436 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.214402e-05 | 4.375 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.949686e-05 | 4.048 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.097709e-04 | 3.960 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.224245e-04 | 3.912 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.185489e-04 | 3.926 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.589851e-04 | 3.799 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.850553e-04 | 3.733 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.213898e-04 | 3.655 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.353594e-04 | 3.628 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.600714e-04 | 3.585 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.855865e-04 | 3.544 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.855865e-04 | 3.544 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.226682e-04 | 3.491 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.142992e-04 | 3.503 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.246827e-04 | 3.280 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.393751e-04 | 3.268 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.100971e-04 | 3.292 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.197656e-04 | 3.208 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.197656e-04 | 3.208 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.748186e-04 | 3.171 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.977020e-04 | 3.156 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.937579e-04 | 3.100 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.937579e-04 | 3.100 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.522435e-04 | 3.124 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.854648e-04 | 3.053 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.627406e-04 | 3.064 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.093971e-03 | 2.961 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.074670e-03 | 2.969 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.297848e-03 | 2.887 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.304112e-03 | 2.885 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.506821e-03 | 2.822 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.573577e-03 | 2.803 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.027371e-03 | 2.693 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.095541e-03 | 2.679 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.172601e-03 | 2.663 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.457147e-03 | 2.610 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.472295e-03 | 2.607 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.472295e-03 | 2.607 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.297106e-03 | 2.639 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.292659e-03 | 2.640 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.454997e-03 | 2.610 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.472295e-03 | 2.607 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.906489e-03 | 2.537 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.857355e-03 | 2.544 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.857355e-03 | 2.544 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.809858e-03 | 2.551 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.196743e-03 | 2.495 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.541902e-03 | 2.451 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.882438e-03 | 2.411 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.397762e-03 | 2.357 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.397762e-03 | 2.357 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.773881e-03 | 2.321 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.157161e-03 | 2.288 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.337024e-03 | 2.273 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.330835e-03 | 2.273 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.084077e-03 | 2.294 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.682716e-03 | 2.245 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.565537e-03 | 2.254 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.486330e-03 | 2.261 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.486330e-03 | 2.261 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.860068e-03 | 2.232 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 6.348247e-03 | 2.197 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.167461e-03 | 2.210 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.408713e-03 | 2.193 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.768115e-03 | 2.170 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.870293e-03 | 2.163 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.910096e-03 | 2.161 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.622620e-03 | 2.118 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.103085e-03 | 2.091 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.103085e-03 | 2.091 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.641368e-03 | 2.117 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.880415e-03 | 2.103 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.106185e-03 | 2.091 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.499251e-03 | 2.022 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 9.499251e-03 | 2.022 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.203941e-03 | 2.036 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.228959e-03 | 2.035 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.286184e-03 | 2.032 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.739670e-03 | 2.059 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.371610e-03 | 2.028 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.648958e-03 | 2.063 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.648958e-03 | 2.063 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.606476e-03 | 2.017 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.864995e-03 | 2.006 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.864995e-03 | 2.006 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 9.864995e-03 | 2.006 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.039258e-02 | 1.983 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.039258e-02 | 1.983 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.024622e-02 | 1.989 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.059575e-02 | 1.975 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.059575e-02 | 1.975 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.154483e-02 | 1.938 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.077855e-02 | 1.967 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.130745e-02 | 1.947 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.073269e-02 | 1.969 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.137959e-02 | 1.944 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.270742e-02 | 1.896 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.370867e-02 | 1.863 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.373741e-02 | 1.862 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.426086e-02 | 1.846 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.563808e-02 | 1.806 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.563808e-02 | 1.806 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.649161e-02 | 1.783 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.866041e-02 | 1.729 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.030084e-02 | 1.692 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.888946e-02 | 1.724 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.054968e-02 | 1.687 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.068945e-02 | 1.684 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.068945e-02 | 1.684 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.085535e-02 | 1.681 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.090988e-02 | 1.680 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.101297e-02 | 1.678 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.114872e-02 | 1.675 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.170287e-02 | 1.663 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.257473e-02 | 1.646 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.291685e-02 | 1.640 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.328160e-02 | 1.633 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.474049e-02 | 1.607 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.363698e-02 | 1.626 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.474049e-02 | 1.607 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.488254e-02 | 1.604 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.495136e-02 | 1.603 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.495136e-02 | 1.603 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.531049e-02 | 1.597 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.531135e-02 | 1.597 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.616802e-02 | 1.582 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.670752e-02 | 1.573 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.752636e-02 | 1.560 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.091710e-02 | 1.510 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.914505e-02 | 1.535 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.149811e-02 | 1.502 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.951298e-02 | 1.530 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.956227e-02 | 1.529 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.914505e-02 | 1.535 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.583438e-02 | 1.446 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.583438e-02 | 1.446 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.583438e-02 | 1.446 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.583438e-02 | 1.446 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.201772e-02 | 1.495 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.201772e-02 | 1.495 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.201772e-02 | 1.495 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.201772e-02 | 1.495 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.201772e-02 | 1.495 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.457731e-02 | 1.461 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.298810e-02 | 1.482 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.438413e-02 | 1.464 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.665781e-02 | 1.436 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.741521e-02 | 1.427 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.784007e-02 | 1.422 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.798196e-02 | 1.420 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.857319e-02 | 1.414 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.857319e-02 | 1.414 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.884370e-02 | 1.411 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.884370e-02 | 1.411 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.996284e-02 | 1.398 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.240401e-02 | 1.373 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.240401e-02 | 1.373 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.724016e-02 | 1.326 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.724016e-02 | 1.326 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.663310e-02 | 1.331 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.427194e-02 | 1.354 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.663310e-02 | 1.331 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.724016e-02 | 1.326 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.171173e-02 | 1.380 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.747870e-02 | 1.324 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.754344e-02 | 1.323 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.903473e-02 | 1.309 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.903473e-02 | 1.309 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.903473e-02 | 1.309 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.903473e-02 | 1.309 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.988029e-02 | 1.302 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.988029e-02 | 1.302 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.988029e-02 | 1.302 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.988029e-02 | 1.302 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.988029e-02 | 1.302 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.106947e-02 | 1.292 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.305162e-02 | 1.275 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.305162e-02 | 1.275 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.893160e-02 | 1.230 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.893160e-02 | 1.230 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.320512e-02 | 1.274 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.441243e-02 | 1.264 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.612358e-02 | 1.251 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.305162e-02 | 1.275 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.305162e-02 | 1.275 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.338181e-02 | 1.273 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.305162e-02 | 1.275 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.994617e-02 | 1.222 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.338181e-02 | 1.273 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.177679e-02 | 1.286 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.203939e-02 | 1.284 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.039120e-02 | 1.219 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.039120e-02 | 1.219 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.039120e-02 | 1.219 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.248939e-02 | 1.204 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.248939e-02 | 1.204 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.252738e-02 | 1.204 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.252738e-02 | 1.204 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.528191e-02 | 1.185 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.587148e-02 | 1.181 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.594098e-02 | 1.181 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.112153e-02 | 1.148 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 7.331035e-02 | 1.135 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.331035e-02 | 1.135 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.285583e-02 | 1.138 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.285583e-02 | 1.138 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.185406e-02 | 1.144 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.375515e-02 | 1.132 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.181168e-02 | 1.144 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.881048e-02 | 1.103 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.421370e-02 | 1.130 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.767364e-02 | 1.170 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.877348e-02 | 1.163 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.421370e-02 | 1.130 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.947427e-02 | 1.158 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.285583e-02 | 1.138 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.027744e-02 | 1.095 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.822030e-02 | 1.166 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.375515e-02 | 1.132 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.186945e-02 | 1.143 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.331035e-02 | 1.135 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.003512e-02 | 1.155 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.881048e-02 | 1.103 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.683849e-02 | 1.114 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.890261e-02 | 1.103 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.181168e-02 | 1.144 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.890261e-02 | 1.103 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.750624e-02 | 1.111 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.189019e-02 | 1.087 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.189019e-02 | 1.087 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.351926e-02 | 1.078 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.360503e-02 | 1.078 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.428965e-02 | 1.074 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.428965e-02 | 1.074 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.617853e-02 | 1.065 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.621865e-02 | 1.064 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.735585e-02 | 1.059 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.993476e-02 | 1.046 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.081825e-02 | 1.042 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.213231e-02 | 1.036 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.257629e-02 | 1.034 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.257629e-02 | 1.034 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.257629e-02 | 1.034 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.257629e-02 | 1.034 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.263181e-02 | 1.033 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.371237e-02 | 1.028 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.391167e-02 | 1.027 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 9.519314e-02 | 1.021 | 0 | 0 |
| IRS activation | R-HSA-74713 | 9.519314e-02 | 1.021 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 9.519314e-02 | 1.021 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.519314e-02 | 1.021 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.000486e-01 | 1.000 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.000486e-01 | 1.000 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.007495e-01 | 0.997 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.008374e-01 | 0.996 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.011739e-01 | 0.995 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.186519e-01 | 0.926 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.186519e-01 | 0.926 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.162035e-01 | 0.935 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.162035e-01 | 0.935 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.038871e-01 | 0.983 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.157942e-01 | 0.936 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.086483e-01 | 0.964 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.017381e-01 | 0.993 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.270415e-01 | 0.896 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.270415e-01 | 0.896 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.157942e-01 | 0.936 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.157942e-01 | 0.936 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.162035e-01 | 0.935 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.186519e-01 | 0.926 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.056410e-01 | 0.976 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.162035e-01 | 0.935 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.091137e-01 | 0.962 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.270415e-01 | 0.896 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.186519e-01 | 0.926 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.162035e-01 | 0.935 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.032200e-01 | 0.986 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.180152e-01 | 0.928 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.186519e-01 | 0.926 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.235543e-01 | 0.908 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.186519e-01 | 0.926 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.267921e-01 | 0.897 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.279567e-01 | 0.893 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.283672e-01 | 0.892 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.283672e-01 | 0.892 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.283672e-01 | 0.892 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.303809e-01 | 0.885 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.371887e-01 | 0.863 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.371887e-01 | 0.863 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.371887e-01 | 0.863 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.371887e-01 | 0.863 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.985605e-01 | 0.702 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.985605e-01 | 0.702 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.985605e-01 | 0.702 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.985605e-01 | 0.702 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.985605e-01 | 0.702 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.985605e-01 | 0.702 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.555704e-01 | 0.592 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.555704e-01 | 0.592 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.555704e-01 | 0.592 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.689992e-01 | 0.772 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.689992e-01 | 0.772 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.689992e-01 | 0.772 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.689992e-01 | 0.772 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.689992e-01 | 0.772 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.085280e-01 | 0.511 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.085280e-01 | 0.511 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.085280e-01 | 0.511 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.085280e-01 | 0.511 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.085280e-01 | 0.511 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.221280e-01 | 0.653 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.221280e-01 | 0.653 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.577213e-01 | 0.446 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.577213e-01 | 0.446 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.577213e-01 | 0.446 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 3.577213e-01 | 0.446 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.577213e-01 | 0.446 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.577213e-01 | 0.446 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 3.577213e-01 | 0.446 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 3.577213e-01 | 0.446 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.668342e-01 | 0.778 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.668342e-01 | 0.778 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 2.491842e-01 | 0.603 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.035453e-01 | 0.691 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.034175e-01 | 0.394 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.034175e-01 | 0.394 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.034143e-01 | 0.518 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.526414e-01 | 0.816 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.418821e-01 | 0.616 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.378196e-01 | 0.861 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.129937e-01 | 0.672 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.303103e-01 | 0.481 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.303103e-01 | 0.481 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.303103e-01 | 0.481 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 4.458652e-01 | 0.351 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 4.458652e-01 | 0.351 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.458652e-01 | 0.351 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.458652e-01 | 0.351 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.458652e-01 | 0.351 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.458652e-01 | 0.351 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.458652e-01 | 0.351 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.284125e-01 | 0.641 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.501886e-01 | 0.823 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.440994e-01 | 0.612 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.440994e-01 | 0.612 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.440994e-01 | 0.612 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.142807e-01 | 0.669 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.497485e-01 | 0.825 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.761263e-01 | 0.559 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.761263e-01 | 0.559 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.211366e-01 | 0.493 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.831117e-01 | 0.417 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.831117e-01 | 0.417 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.852950e-01 | 0.314 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.852950e-01 | 0.314 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.852950e-01 | 0.314 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.852950e-01 | 0.314 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.852950e-01 | 0.314 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.852950e-01 | 0.314 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.652340e-01 | 0.782 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.354856e-01 | 0.628 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.682733e-01 | 0.571 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.822267e-01 | 0.549 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.610507e-01 | 0.442 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.610507e-01 | 0.442 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.850980e-01 | 0.733 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.422717e-01 | 0.616 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.808908e-01 | 0.419 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.808908e-01 | 0.419 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.340415e-01 | 0.362 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.340415e-01 | 0.362 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.340415e-01 | 0.362 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.219213e-01 | 0.282 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.219213e-01 | 0.282 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.219213e-01 | 0.282 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.583262e-01 | 0.446 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.586476e-01 | 0.339 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.586476e-01 | 0.339 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.352227e-01 | 0.475 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.913663e-01 | 0.407 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.571396e-01 | 0.590 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.762295e-01 | 0.559 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.059232e-01 | 0.296 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.059232e-01 | 0.296 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.772341e-01 | 0.321 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.772341e-01 | 0.321 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.772341e-01 | 0.321 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.564708e-01 | 0.341 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.564708e-01 | 0.341 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.135496e-01 | 0.383 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.285322e-01 | 0.277 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.681296e-01 | 0.330 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.881610e-01 | 0.311 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.881610e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.881610e-01 | 0.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.037209e-01 | 0.298 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.190684e-01 | 0.285 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.200501e-01 | 0.284 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.034816e-01 | 0.691 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.254057e-01 | 0.371 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.571396e-01 | 0.590 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.480042e-01 | 0.830 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.682733e-01 | 0.571 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.724050e-01 | 0.326 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.724050e-01 | 0.326 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.418821e-01 | 0.616 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.772341e-01 | 0.321 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.581657e-01 | 0.339 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.958704e-01 | 0.529 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.581657e-01 | 0.339 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.581657e-01 | 0.339 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.087790e-01 | 0.510 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.844438e-01 | 0.546 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.682733e-01 | 0.571 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.749508e-01 | 0.323 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.564708e-01 | 0.341 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.088450e-01 | 0.388 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.812567e-01 | 0.551 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.274585e-01 | 0.643 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.610507e-01 | 0.442 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.252521e-01 | 0.488 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.508718e-01 | 0.601 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.895553e-01 | 0.722 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.895553e-01 | 0.722 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.740053e-01 | 0.427 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.035453e-01 | 0.691 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.698533e-01 | 0.569 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.689992e-01 | 0.772 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.689992e-01 | 0.772 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.491842e-01 | 0.603 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.491842e-01 | 0.603 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.763294e-01 | 0.559 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.526414e-01 | 0.816 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.544784e-01 | 0.594 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.682733e-01 | 0.571 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.078024e-01 | 0.390 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.583262e-01 | 0.446 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.182390e-01 | 0.661 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.352227e-01 | 0.475 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.824394e-01 | 0.417 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.231930e-01 | 0.281 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.248247e-01 | 0.648 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.221280e-01 | 0.653 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.034175e-01 | 0.394 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.034143e-01 | 0.518 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.303103e-01 | 0.481 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.458652e-01 | 0.351 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.569072e-01 | 0.447 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.822136e-01 | 0.739 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.258989e-01 | 0.487 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.138213e-01 | 0.289 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.834227e-01 | 0.416 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.698533e-01 | 0.569 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.643274e-01 | 0.784 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.497485e-01 | 0.825 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.832751e-01 | 0.548 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.851200e-01 | 0.314 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.851200e-01 | 0.314 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.660619e-01 | 0.436 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.474726e-01 | 0.606 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.981445e-01 | 0.526 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.129937e-01 | 0.672 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.303103e-01 | 0.481 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.732501e-01 | 0.761 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.407894e-01 | 0.468 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.689992e-01 | 0.772 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.034175e-01 | 0.394 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.034175e-01 | 0.394 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.034143e-01 | 0.518 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.680177e-01 | 0.775 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.762295e-01 | 0.559 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.826195e-01 | 0.316 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.241477e-01 | 0.372 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.018976e-01 | 0.520 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.059232e-01 | 0.296 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.956940e-01 | 0.305 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.769638e-01 | 0.322 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.190684e-01 | 0.285 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.789468e-01 | 0.554 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.845429e-01 | 0.415 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.776778e-01 | 0.321 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.891991e-01 | 0.723 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.805362e-01 | 0.420 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.668342e-01 | 0.778 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.569072e-01 | 0.447 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.129937e-01 | 0.672 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.953336e-01 | 0.709 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.221280e-01 | 0.653 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.643274e-01 | 0.784 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.340415e-01 | 0.362 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.219213e-01 | 0.282 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.826195e-01 | 0.316 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.826195e-01 | 0.316 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.897970e-01 | 0.409 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.285322e-01 | 0.277 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.412684e-01 | 0.467 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.034143e-01 | 0.518 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.378196e-01 | 0.861 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.378196e-01 | 0.861 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.812567e-01 | 0.551 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.852950e-01 | 0.314 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.190684e-01 | 0.285 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.093218e-01 | 0.293 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.225484e-01 | 0.653 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.303103e-01 | 0.481 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.425443e-01 | 0.846 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.813516e-01 | 0.551 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.944429e-01 | 0.306 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.340415e-01 | 0.362 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.252521e-01 | 0.488 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.148428e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.963155e-01 | 0.528 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.483975e-01 | 0.605 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.371887e-01 | 0.863 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.985605e-01 | 0.702 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.985605e-01 | 0.702 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.555704e-01 | 0.592 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.555704e-01 | 0.592 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.555704e-01 | 0.592 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.085280e-01 | 0.511 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.085280e-01 | 0.511 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.492842e-01 | 0.826 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.577213e-01 | 0.446 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.491842e-01 | 0.603 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 2.763294e-01 | 0.559 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.034175e-01 | 0.394 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.034175e-01 | 0.394 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.687318e-01 | 0.773 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.831146e-01 | 0.737 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.831146e-01 | 0.737 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.034143e-01 | 0.518 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.034143e-01 | 0.518 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.418821e-01 | 0.616 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.458652e-01 | 0.351 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.458652e-01 | 0.351 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.458652e-01 | 0.351 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.569072e-01 | 0.447 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.425474e-01 | 0.846 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.007036e-01 | 0.697 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.852950e-01 | 0.314 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.417784e-01 | 0.466 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.340415e-01 | 0.362 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.586476e-01 | 0.339 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.151242e-01 | 0.502 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.394144e-01 | 0.357 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.059232e-01 | 0.296 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.059232e-01 | 0.296 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.258205e-01 | 0.371 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.540440e-01 | 0.343 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.540440e-01 | 0.343 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.285322e-01 | 0.277 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.285322e-01 | 0.277 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.750259e-01 | 0.323 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.344869e-01 | 0.630 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.399087e-01 | 0.620 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.059232e-01 | 0.296 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.748651e-01 | 0.426 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.999452e-01 | 0.398 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.202542e-01 | 0.495 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.911465e-01 | 0.536 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.227039e-01 | 0.374 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.895553e-01 | 0.722 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.211366e-01 | 0.493 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.138213e-01 | 0.289 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.988901e-01 | 0.701 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.923923e-01 | 0.534 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.088450e-01 | 0.388 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.201119e-01 | 0.377 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.560615e-01 | 0.341 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.769192e-01 | 0.752 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.772341e-01 | 0.321 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.285322e-01 | 0.277 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.472753e-01 | 0.459 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.491842e-01 | 0.603 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.035453e-01 | 0.691 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.034175e-01 | 0.394 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.614744e-01 | 0.583 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.011644e-01 | 0.521 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.831117e-01 | 0.417 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.144252e-01 | 0.289 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.193586e-01 | 0.285 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.913663e-01 | 0.407 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.235607e-01 | 0.651 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.480042e-01 | 0.830 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.881610e-01 | 0.311 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.544908e-01 | 0.342 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.846161e-01 | 0.415 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.221280e-01 | 0.653 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.577213e-01 | 0.446 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.303103e-01 | 0.481 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.411163e-01 | 0.467 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.822267e-01 | 0.549 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.018659e-01 | 0.396 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.525631e-01 | 0.598 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.070110e-01 | 0.684 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.620524e-01 | 0.582 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.600165e-01 | 0.585 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.005915e-01 | 0.397 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.496903e-01 | 0.347 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.211366e-01 | 0.493 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.586476e-01 | 0.339 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.415691e-01 | 0.617 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.869764e-01 | 0.412 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.110887e-01 | 0.292 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.845770e-01 | 0.315 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.814575e-01 | 0.741 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.848390e-01 | 0.545 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.396847e-01 | 0.357 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.779468e-01 | 0.750 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.731270e-01 | 0.564 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.985605e-01 | 0.702 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 3.577213e-01 | 0.446 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.458652e-01 | 0.351 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.142807e-01 | 0.669 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.852950e-01 | 0.314 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 4.340415e-01 | 0.362 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.219213e-01 | 0.282 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.583262e-01 | 0.446 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.096276e-01 | 0.509 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.586476e-01 | 0.339 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.138213e-01 | 0.289 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.933115e-01 | 0.405 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.211366e-01 | 0.493 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.748651e-01 | 0.426 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.571396e-01 | 0.590 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.681296e-01 | 0.330 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.138213e-01 | 0.289 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.822267e-01 | 0.549 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.005915e-01 | 0.397 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.724050e-01 | 0.326 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.323798e-01 | 0.878 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 3.610507e-01 | 0.442 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.235914e-01 | 0.373 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.584652e-01 | 0.339 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.433522e-01 | 0.844 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.085280e-01 | 0.511 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.668342e-01 | 0.778 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.491842e-01 | 0.603 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.034816e-01 | 0.691 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.252521e-01 | 0.488 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.391317e-01 | 0.470 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.093218e-01 | 0.293 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.088450e-01 | 0.388 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.025757e-01 | 0.395 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.418017e-01 | 0.848 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.391669e-01 | 0.470 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.201119e-01 | 0.377 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.352227e-01 | 0.475 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.016765e-01 | 0.396 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.689992e-01 | 0.772 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.689992e-01 | 0.772 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.085280e-01 | 0.511 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.221280e-01 | 0.653 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.849479e-01 | 0.733 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.475869e-01 | 0.831 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.458652e-01 | 0.351 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.569072e-01 | 0.447 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.852950e-01 | 0.314 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.852950e-01 | 0.314 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.219213e-01 | 0.282 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.219213e-01 | 0.282 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.524236e-01 | 0.817 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.403781e-01 | 0.356 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.921978e-01 | 0.534 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.256161e-01 | 0.487 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.011644e-01 | 0.521 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.162812e-01 | 0.287 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.151242e-01 | 0.502 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.831146e-01 | 0.737 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.831146e-01 | 0.737 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.847195e-01 | 0.733 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.547712e-01 | 0.810 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.411163e-01 | 0.467 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.187794e-01 | 0.285 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.284125e-01 | 0.641 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.258205e-01 | 0.371 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.258205e-01 | 0.371 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.112504e-01 | 0.386 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.953336e-01 | 0.709 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.034175e-01 | 0.394 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.458652e-01 | 0.351 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.011644e-01 | 0.521 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.120852e-01 | 0.673 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.088450e-01 | 0.388 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.625332e-01 | 0.581 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.059232e-01 | 0.296 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.246142e-01 | 0.372 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.108748e-01 | 0.676 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.844726e-01 | 0.734 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.303103e-01 | 0.481 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.491842e-01 | 0.603 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.959434e-01 | 0.305 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.037209e-01 | 0.298 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.591672e-01 | 0.586 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.128977e-01 | 0.384 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.692589e-01 | 0.329 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.956940e-01 | 0.305 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.303103e-01 | 0.481 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.979963e-01 | 0.703 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.676540e-01 | 0.572 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.059232e-01 | 0.296 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.895553e-01 | 0.722 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.417784e-01 | 0.466 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.586476e-01 | 0.339 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.491842e-01 | 0.603 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.285322e-01 | 0.277 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.059232e-01 | 0.296 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 5.219213e-01 | 0.282 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.341884e-01 | 0.272 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.365765e-01 | 0.270 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.375178e-01 | 0.270 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.388211e-01 | 0.269 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.429791e-01 | 0.265 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.454005e-01 | 0.263 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.489972e-01 | 0.260 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.489972e-01 | 0.260 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.489972e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.490674e-01 | 0.260 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.490674e-01 | 0.260 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.495055e-01 | 0.260 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.497851e-01 | 0.260 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.504276e-01 | 0.259 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.504276e-01 | 0.259 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.504276e-01 | 0.259 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.504276e-01 | 0.259 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.504276e-01 | 0.259 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.520118e-01 | 0.258 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.523477e-01 | 0.258 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.559433e-01 | 0.255 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.559433e-01 | 0.255 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.559433e-01 | 0.255 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.559433e-01 | 0.255 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.559433e-01 | 0.255 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.559433e-01 | 0.255 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.559433e-01 | 0.255 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.559433e-01 | 0.255 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.559433e-01 | 0.255 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.559433e-01 | 0.255 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 5.559433e-01 | 0.255 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.559433e-01 | 0.255 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.559433e-01 | 0.255 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.636933e-01 | 0.249 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.660127e-01 | 0.247 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.660127e-01 | 0.247 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.715962e-01 | 0.243 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.715962e-01 | 0.243 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.715962e-01 | 0.243 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.715962e-01 | 0.243 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.736595e-01 | 0.241 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.743776e-01 | 0.241 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.746730e-01 | 0.241 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.756401e-01 | 0.240 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.826285e-01 | 0.235 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.826285e-01 | 0.235 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.826285e-01 | 0.235 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.826285e-01 | 0.235 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.832620e-01 | 0.234 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.836768e-01 | 0.234 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.875461e-01 | 0.231 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.875461e-01 | 0.231 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.875461e-01 | 0.231 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 5.875461e-01 | 0.231 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.875461e-01 | 0.231 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.875461e-01 | 0.231 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.875461e-01 | 0.231 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.875461e-01 | 0.231 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.875461e-01 | 0.231 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.875461e-01 | 0.231 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.875461e-01 | 0.231 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.920308e-01 | 0.228 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.008172e-01 | 0.221 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.018671e-01 | 0.220 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.059501e-01 | 0.218 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.059501e-01 | 0.218 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.117285e-01 | 0.213 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.117285e-01 | 0.213 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.117285e-01 | 0.213 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.117285e-01 | 0.213 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.117285e-01 | 0.213 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.117285e-01 | 0.213 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.117285e-01 | 0.213 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.117285e-01 | 0.213 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.128974e-01 | 0.213 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.146217e-01 | 0.211 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.146217e-01 | 0.211 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.146217e-01 | 0.211 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.146217e-01 | 0.211 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.169016e-01 | 0.210 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.169016e-01 | 0.210 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.169016e-01 | 0.210 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.169016e-01 | 0.210 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.169016e-01 | 0.210 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.169016e-01 | 0.210 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.169016e-01 | 0.210 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.169016e-01 | 0.210 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.169016e-01 | 0.210 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.169016e-01 | 0.210 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.169016e-01 | 0.210 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.194676e-01 | 0.208 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.299844e-01 | 0.201 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.306908e-01 | 0.200 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.306908e-01 | 0.200 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.306908e-01 | 0.200 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.306908e-01 | 0.200 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.326902e-01 | 0.199 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.410988e-01 | 0.193 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.441693e-01 | 0.191 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.441693e-01 | 0.191 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.441693e-01 | 0.191 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.441693e-01 | 0.191 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.441693e-01 | 0.191 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.441693e-01 | 0.191 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.441693e-01 | 0.191 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.441693e-01 | 0.191 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.441693e-01 | 0.191 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.441693e-01 | 0.191 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.456128e-01 | 0.190 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.456128e-01 | 0.190 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.456128e-01 | 0.190 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.489224e-01 | 0.188 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.502068e-01 | 0.187 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.554208e-01 | 0.183 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.566252e-01 | 0.183 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.649374e-01 | 0.177 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.664314e-01 | 0.176 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.664314e-01 | 0.176 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.664314e-01 | 0.176 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 6.664314e-01 | 0.176 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.664314e-01 | 0.176 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.694978e-01 | 0.174 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.694978e-01 | 0.174 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.694978e-01 | 0.174 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.694978e-01 | 0.174 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.694978e-01 | 0.174 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.694978e-01 | 0.174 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.734885e-01 | 0.172 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.734885e-01 | 0.172 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.734885e-01 | 0.172 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.734885e-01 | 0.172 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.742916e-01 | 0.171 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.813508e-01 | 0.167 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.813508e-01 | 0.167 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.813508e-01 | 0.167 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.825462e-01 | 0.166 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.832282e-01 | 0.165 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.832282e-01 | 0.165 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.834811e-01 | 0.165 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.866439e-01 | 0.163 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.871245e-01 | 0.163 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.919303e-01 | 0.160 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.925042e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.925042e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.925042e-01 | 0.160 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.930247e-01 | 0.159 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.930247e-01 | 0.159 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.930247e-01 | 0.159 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.930247e-01 | 0.159 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.930247e-01 | 0.159 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.930247e-01 | 0.159 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.930247e-01 | 0.159 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.930247e-01 | 0.159 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.930247e-01 | 0.159 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.930247e-01 | 0.159 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.930247e-01 | 0.159 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.930247e-01 | 0.159 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.930247e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.930247e-01 | 0.159 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.930247e-01 | 0.159 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.941017e-01 | 0.159 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.941017e-01 | 0.159 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.942386e-01 | 0.158 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.993255e-01 | 0.155 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.993255e-01 | 0.155 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.993255e-01 | 0.155 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.993255e-01 | 0.155 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.000416e-01 | 0.155 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.003292e-01 | 0.155 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.003292e-01 | 0.155 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.003292e-01 | 0.155 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.011500e-01 | 0.154 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.081828e-01 | 0.150 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.100452e-01 | 0.149 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.131054e-01 | 0.147 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.131054e-01 | 0.147 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.147377e-01 | 0.146 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.147377e-01 | 0.146 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.147377e-01 | 0.146 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.148782e-01 | 0.146 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.148782e-01 | 0.146 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.148782e-01 | 0.146 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.148782e-01 | 0.146 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.148782e-01 | 0.146 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.148782e-01 | 0.146 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.222106e-01 | 0.141 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.222106e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.254567e-01 | 0.139 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.264292e-01 | 0.139 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.269055e-01 | 0.139 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.294807e-01 | 0.137 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.294807e-01 | 0.137 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.294807e-01 | 0.137 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.294807e-01 | 0.137 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.294807e-01 | 0.137 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.351771e-01 | 0.134 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.351771e-01 | 0.134 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.351771e-01 | 0.134 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.351771e-01 | 0.134 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.351771e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.351771e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.351771e-01 | 0.134 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.351771e-01 | 0.134 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.372201e-01 | 0.132 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.379061e-01 | 0.132 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.379061e-01 | 0.132 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.379061e-01 | 0.132 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.379061e-01 | 0.132 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.379061e-01 | 0.132 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.412068e-01 | 0.130 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.419594e-01 | 0.130 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.430803e-01 | 0.129 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.435718e-01 | 0.129 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.435718e-01 | 0.129 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.480533e-01 | 0.126 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.480533e-01 | 0.126 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.489048e-01 | 0.126 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.489048e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.489048e-01 | 0.126 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.491112e-01 | 0.125 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.509101e-01 | 0.124 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.540320e-01 | 0.123 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.540320e-01 | 0.123 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.540320e-01 | 0.123 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.540320e-01 | 0.123 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.540320e-01 | 0.123 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.540320e-01 | 0.123 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.540320e-01 | 0.123 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.540320e-01 | 0.123 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.540320e-01 | 0.123 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.540320e-01 | 0.123 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.540320e-01 | 0.123 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.540320e-01 | 0.123 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.540320e-01 | 0.123 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.540320e-01 | 0.123 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.540320e-01 | 0.123 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.540320e-01 | 0.123 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.540488e-01 | 0.123 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.540488e-01 | 0.123 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.570289e-01 | 0.121 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.570289e-01 | 0.121 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.578970e-01 | 0.120 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.600134e-01 | 0.119 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.600134e-01 | 0.119 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.600134e-01 | 0.119 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.674095e-01 | 0.115 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.674403e-01 | 0.115 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.698708e-01 | 0.114 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.698708e-01 | 0.114 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.707206e-01 | 0.113 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.715456e-01 | 0.113 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.715456e-01 | 0.113 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.715456e-01 | 0.113 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.737513e-01 | 0.111 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.762210e-01 | 0.110 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.762210e-01 | 0.110 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.766869e-01 | 0.110 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.805195e-01 | 0.108 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.810340e-01 | 0.107 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.810340e-01 | 0.107 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.821170e-01 | 0.107 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.821170e-01 | 0.107 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.821170e-01 | 0.107 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.821170e-01 | 0.107 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.821170e-01 | 0.107 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.821170e-01 | 0.107 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.874979e-01 | 0.104 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.878131e-01 | 0.104 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.878131e-01 | 0.104 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.878131e-01 | 0.104 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.878131e-01 | 0.104 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.878131e-01 | 0.104 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.937872e-01 | 0.100 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.937872e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.937872e-01 | 0.100 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.937872e-01 | 0.100 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.005117e-01 | 0.097 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.005117e-01 | 0.097 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.026867e-01 | 0.095 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.026867e-01 | 0.095 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.029231e-01 | 0.095 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.029231e-01 | 0.095 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.029231e-01 | 0.095 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.029231e-01 | 0.095 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.029231e-01 | 0.095 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.029231e-01 | 0.095 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.029231e-01 | 0.095 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.029231e-01 | 0.095 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.029231e-01 | 0.095 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.029231e-01 | 0.095 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.029231e-01 | 0.095 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.029231e-01 | 0.095 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.049012e-01 | 0.094 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.049012e-01 | 0.094 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.049012e-01 | 0.094 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.049012e-01 | 0.094 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.085612e-01 | 0.092 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.116008e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.137492e-01 | 0.090 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.147551e-01 | 0.089 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.154790e-01 | 0.089 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.154790e-01 | 0.089 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.154790e-01 | 0.089 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.169359e-01 | 0.088 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.169580e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.169580e-01 | 0.088 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.169580e-01 | 0.088 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.169580e-01 | 0.088 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.169580e-01 | 0.088 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.169580e-01 | 0.088 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.169990e-01 | 0.088 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.169990e-01 | 0.088 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.169990e-01 | 0.088 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.185151e-01 | 0.087 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.186167e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.190328e-01 | 0.087 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.194034e-01 | 0.087 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.224690e-01 | 0.085 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.255406e-01 | 0.083 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.255406e-01 | 0.083 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.255406e-01 | 0.083 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.255406e-01 | 0.083 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.255406e-01 | 0.083 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.255406e-01 | 0.083 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.269866e-01 | 0.083 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.269866e-01 | 0.083 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.269866e-01 | 0.083 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.299942e-01 | 0.081 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.299942e-01 | 0.081 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.299942e-01 | 0.081 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.299942e-01 | 0.081 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.299942e-01 | 0.081 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.299942e-01 | 0.081 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.299942e-01 | 0.081 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.334725e-01 | 0.079 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.334725e-01 | 0.079 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.346074e-01 | 0.079 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.351059e-01 | 0.078 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.351171e-01 | 0.078 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.351171e-01 | 0.078 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.352048e-01 | 0.078 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.405114e-01 | 0.075 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.405114e-01 | 0.075 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.411763e-01 | 0.075 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.414629e-01 | 0.075 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.415974e-01 | 0.075 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.421026e-01 | 0.075 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.421026e-01 | 0.075 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.421026e-01 | 0.075 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.421026e-01 | 0.075 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.421026e-01 | 0.075 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.429163e-01 | 0.074 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.429163e-01 | 0.074 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.435014e-01 | 0.074 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.441945e-01 | 0.074 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.441945e-01 | 0.074 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.456880e-01 | 0.073 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.472988e-01 | 0.072 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.503937e-01 | 0.070 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.503937e-01 | 0.070 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.518303e-01 | 0.070 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.528258e-01 | 0.069 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.528258e-01 | 0.069 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.533494e-01 | 0.069 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.533494e-01 | 0.069 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.533494e-01 | 0.069 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.533494e-01 | 0.069 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.533494e-01 | 0.069 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.533494e-01 | 0.069 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.533494e-01 | 0.069 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.533494e-01 | 0.069 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.586291e-01 | 0.066 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.586291e-01 | 0.066 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.595586e-01 | 0.066 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.601428e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.609857e-01 | 0.065 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.610187e-01 | 0.065 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.637956e-01 | 0.064 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.637956e-01 | 0.064 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.637956e-01 | 0.064 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.637956e-01 | 0.064 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.637956e-01 | 0.064 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.637956e-01 | 0.064 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.637956e-01 | 0.064 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.705606e-01 | 0.060 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.705606e-01 | 0.060 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.705606e-01 | 0.060 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.709923e-01 | 0.060 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.711665e-01 | 0.060 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.720527e-01 | 0.059 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.725104e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.730135e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.730135e-01 | 0.059 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.734984e-01 | 0.059 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.734984e-01 | 0.059 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.734984e-01 | 0.059 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.734984e-01 | 0.059 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.734984e-01 | 0.059 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.734984e-01 | 0.059 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.756136e-01 | 0.058 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.761637e-01 | 0.057 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.761637e-01 | 0.057 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.761637e-01 | 0.057 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.761637e-01 | 0.057 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.775311e-01 | 0.057 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.775311e-01 | 0.057 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.776726e-01 | 0.057 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.798294e-01 | 0.056 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.808246e-01 | 0.055 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.808246e-01 | 0.055 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.825105e-01 | 0.054 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.825105e-01 | 0.054 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.825105e-01 | 0.054 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.825105e-01 | 0.054 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.831516e-01 | 0.054 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.831516e-01 | 0.054 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.852652e-01 | 0.053 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.852652e-01 | 0.053 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.852652e-01 | 0.053 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.856909e-01 | 0.053 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.879076e-01 | 0.052 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.890426e-01 | 0.051 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.890426e-01 | 0.051 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.890426e-01 | 0.051 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.897730e-01 | 0.051 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.903858e-01 | 0.050 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.908810e-01 | 0.050 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.908810e-01 | 0.050 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.908810e-01 | 0.050 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.908810e-01 | 0.050 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.908810e-01 | 0.050 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.932660e-01 | 0.049 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.959799e-01 | 0.048 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.960447e-01 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.960447e-01 | 0.048 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.973506e-01 | 0.047 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.986557e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.986557e-01 | 0.046 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.986557e-01 | 0.046 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.986557e-01 | 0.046 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.986557e-01 | 0.046 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.986557e-01 | 0.046 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.986557e-01 | 0.046 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.986557e-01 | 0.046 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.019827e-01 | 0.045 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.019827e-01 | 0.045 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.019827e-01 | 0.045 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.019827e-01 | 0.045 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.019827e-01 | 0.045 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.019827e-01 | 0.045 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.020138e-01 | 0.045 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.026671e-01 | 0.044 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.034860e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.034860e-01 | 0.044 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.041192e-01 | 0.044 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.047985e-01 | 0.043 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.058768e-01 | 0.043 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.058768e-01 | 0.043 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.058768e-01 | 0.043 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.058768e-01 | 0.043 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.058768e-01 | 0.043 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.058768e-01 | 0.043 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.084128e-01 | 0.042 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.125839e-01 | 0.040 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.125839e-01 | 0.040 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.125839e-01 | 0.040 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.125839e-01 | 0.040 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.125839e-01 | 0.040 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.125839e-01 | 0.040 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.125839e-01 | 0.040 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.125839e-01 | 0.040 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.125839e-01 | 0.040 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.125839e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.125839e-01 | 0.040 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.125839e-01 | 0.040 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.129202e-01 | 0.040 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.129202e-01 | 0.040 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.152010e-01 | 0.038 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.153966e-01 | 0.038 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.188133e-01 | 0.037 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.188133e-01 | 0.037 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.188133e-01 | 0.037 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.188133e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.217960e-01 | 0.035 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.222985e-01 | 0.035 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.227045e-01 | 0.035 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.245992e-01 | 0.034 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.245992e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.245992e-01 | 0.034 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.245992e-01 | 0.034 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.245992e-01 | 0.034 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.256459e-01 | 0.034 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.266122e-01 | 0.033 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.266122e-01 | 0.033 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.268431e-01 | 0.033 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.299731e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.299731e-01 | 0.032 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.299731e-01 | 0.032 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.299731e-01 | 0.032 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.303831e-01 | 0.031 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.303831e-01 | 0.031 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.314458e-01 | 0.031 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.314458e-01 | 0.031 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.326470e-01 | 0.030 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.339750e-01 | 0.030 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.343821e-01 | 0.029 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.349321e-01 | 0.029 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.349643e-01 | 0.029 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.349643e-01 | 0.029 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.349643e-01 | 0.029 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.354574e-01 | 0.029 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.372922e-01 | 0.028 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.384648e-01 | 0.028 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.392458e-01 | 0.027 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.396000e-01 | 0.027 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.396000e-01 | 0.027 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.396493e-01 | 0.027 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.400990e-01 | 0.027 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.402249e-01 | 0.027 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.439055e-01 | 0.025 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.439055e-01 | 0.025 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.476467e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.479044e-01 | 0.023 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.479044e-01 | 0.023 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.479044e-01 | 0.023 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.479455e-01 | 0.023 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.493834e-01 | 0.023 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.516184e-01 | 0.022 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.516184e-01 | 0.022 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.516184e-01 | 0.022 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.516184e-01 | 0.022 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.516184e-01 | 0.022 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.516184e-01 | 0.022 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.516184e-01 | 0.022 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.516184e-01 | 0.022 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.516184e-01 | 0.022 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.516184e-01 | 0.022 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.521662e-01 | 0.021 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.549326e-01 | 0.020 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.550678e-01 | 0.020 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.550678e-01 | 0.020 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.550678e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.550678e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.550678e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.550678e-01 | 0.020 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.550678e-01 | 0.020 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.552221e-01 | 0.020 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.571076e-01 | 0.019 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.578942e-01 | 0.019 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.582715e-01 | 0.019 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.582715e-01 | 0.019 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.587897e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.604131e-01 | 0.018 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.612470e-01 | 0.017 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.612470e-01 | 0.017 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.612470e-01 | 0.017 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.612470e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.612470e-01 | 0.017 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.619136e-01 | 0.017 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.624890e-01 | 0.017 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.627871e-01 | 0.016 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.627871e-01 | 0.016 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.629347e-01 | 0.016 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.637022e-01 | 0.016 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.640104e-01 | 0.016 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.640104e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.640104e-01 | 0.016 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.640104e-01 | 0.016 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.649975e-01 | 0.015 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.665770e-01 | 0.015 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.665770e-01 | 0.015 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.665770e-01 | 0.015 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.665770e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.669143e-01 | 0.015 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.681110e-01 | 0.014 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.689606e-01 | 0.014 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.689606e-01 | 0.014 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.689606e-01 | 0.014 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.689606e-01 | 0.014 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.691638e-01 | 0.014 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.699702e-01 | 0.013 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.709852e-01 | 0.013 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.711744e-01 | 0.013 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.711744e-01 | 0.013 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.711744e-01 | 0.013 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.711744e-01 | 0.013 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.716966e-01 | 0.012 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.718134e-01 | 0.012 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.718513e-01 | 0.012 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.732304e-01 | 0.012 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.732304e-01 | 0.012 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.744013e-01 | 0.011 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.751399e-01 | 0.011 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.759603e-01 | 0.011 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.759603e-01 | 0.011 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.759603e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.767525e-01 | 0.010 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.767525e-01 | 0.010 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.768180e-01 | 0.010 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.769133e-01 | 0.010 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.769133e-01 | 0.010 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.785603e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.785603e-01 | 0.009 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.785603e-01 | 0.009 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.785603e-01 | 0.009 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.788073e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.789731e-01 | 0.009 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.796706e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.800899e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.800899e-01 | 0.009 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.800899e-01 | 0.009 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.800899e-01 | 0.009 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.801054e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.814846e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.815104e-01 | 0.008 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.815104e-01 | 0.008 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.815104e-01 | 0.008 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.815104e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.828297e-01 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.832880e-01 | 0.007 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.835539e-01 | 0.007 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.840549e-01 | 0.007 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.840549e-01 | 0.007 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.840549e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.843852e-01 | 0.007 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.845685e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.851928e-01 | 0.006 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.851928e-01 | 0.006 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.851928e-01 | 0.006 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.852879e-01 | 0.006 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.855222e-01 | 0.006 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.855960e-01 | 0.006 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.859341e-01 | 0.006 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.863265e-01 | 0.006 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.868154e-01 | 0.006 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.872308e-01 | 0.006 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.872308e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.872308e-01 | 0.006 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.872308e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.872606e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.880518e-01 | 0.005 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.881422e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.889886e-01 | 0.005 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.893331e-01 | 0.005 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.894629e-01 | 0.005 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.911825e-01 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.911825e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.918120e-01 | 0.004 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.923966e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.928717e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.929395e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.929395e-01 | 0.003 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.933202e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.934437e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.934437e-01 | 0.003 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.935507e-01 | 0.003 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.935507e-01 | 0.003 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.938532e-01 | 0.003 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.943467e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.945063e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.945888e-01 | 0.002 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.947504e-01 | 0.002 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.947504e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.954851e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.957969e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.960972e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.965283e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.967496e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.970224e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.970224e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.970986e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.971515e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.973304e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.973589e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.974985e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.975044e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.976289e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.981406e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.982735e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.986282e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.986356e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.988085e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.990112e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.991417e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.991779e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.991950e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.992913e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993443e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.994734e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.994786e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.995110e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.995562e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.995785e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.995832e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.996367e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.996868e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.997093e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.997784e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997840e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998138e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.998507e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998716e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998770e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998808e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998894e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999236e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999236e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999292e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999292e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999448e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999611e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999644e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999710e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999768e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999814e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999831e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999891e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999896e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999898e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999926e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999951e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999951e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999960e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999972e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999985e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999986e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999986e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999991e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999994e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |